TWI419970B - A method to producing a spheroid population of adult stem cells - Google Patents

A method to producing a spheroid population of adult stem cells Download PDF

Info

Publication number
TWI419970B
TWI419970B TW099138813A TW99138813A TWI419970B TW I419970 B TWI419970 B TW I419970B TW 099138813 A TW099138813 A TW 099138813A TW 99138813 A TW99138813 A TW 99138813A TW I419970 B TWI419970 B TW I419970B
Authority
TW
Taiwan
Prior art keywords
stem cells
chitosan
cell
cells
stem cell
Prior art date
Application number
TW099138813A
Other languages
Chinese (zh)
Other versions
TW201219572A (en
Inventor
Shan Hui Hsu
Original Assignee
Univ Nat Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Taiwan filed Critical Univ Nat Taiwan
Priority to TW099138813A priority Critical patent/TWI419970B/en
Priority to CN201110355162.3A priority patent/CN102533640B/en
Publication of TW201219572A publication Critical patent/TW201219572A/en
Application granted granted Critical
Publication of TWI419970B publication Critical patent/TWI419970B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

使成體幹細胞產生為一球體細胞群體的方法Method for producing adult stem cells as a spheroid cell population

本發明係關於一種成體幹細胞之培養方法,尤其是有關一種應用生物相容性高分子使成體幹細胞聚集成球體且分化能力提升的方法。The present invention relates to a method for culturing adult stem cells, and more particularly to a method for using a biocompatible polymer to aggregate adult stem cells into spheres and to improve differentiation ability.

幹細胞為一種尚未分化完全的細胞,具有自我更新(self-renew)與分化的可塑性,在組織工程以及再生醫學的應用上極具潛力;幹細胞根據分化的潛能,分為全能幹細胞(totipotent stem cells)、三胚層多能幹細胞(multipotent stem cells)、單胚層多潛能幹細胞(pluripotent stem cells)與單能幹細胞(unipotent stem cells),例如:桑椹胚(morula)之前的每個細胞都保有全能性,也就是將任一個細胞放在子宮中都可以發育成一個完整的個體,具這種潛能的細胞稱為全能幹細胞。單獨只有內細胞團塊(inner cell mass)的細胞,雖然無法發育成整個個體(因為缺乏分化成滋養外胚層的能力,滋養外胚層之後會分化成羊膜和胎盤),但具有發展成個體過程中分化為各種細胞的能力,稱為三胚層多能幹細胞。間葉幹細胞(mesenchymal stem cells,MSCs)能分化成硬骨、軟骨、脂肪和其他結締組織或轉分化為神經細胞、肝臟細胞等,稱為單胚層多潛能幹細胞。神經幹細胞(neural stem cell)只能分化成神經元或是神經膠細胞,稱為單能幹細胞。Stem cells are cells that have not yet fully differentiated, have self-renew and differentiated plasticity, and have great potential in tissue engineering and regenerative medicine; stem cells are divided into totipotent stem cells according to their potential for differentiation. , multipotent stem cells, pluripotent stem cells, and unipotent stem cells, for example, every cell before morula retains pluripotency. That is, any cell can be developed into a complete individual in the uterus, and cells with this potential are called pluripotent stem cells. Cells with only inner cell mass alone, although unable to develop into the entire individual (because of the lack of ability to differentiate into trophectoderm, will differentiate into amniotic membrane and placenta after trophoblast development), but have evolved into individual processes The ability to differentiate into various cells, called the three germ layer pluripotent stem cells. Mesenchymal stem cells (MSCs) can differentiate into hard bone, cartilage, fat and other connective tissues or transdifferentiate into nerve cells, liver cells, etc., called single germ layer pluripotent stem cells. Neural stem cells can only differentiate into neurons or glial cells, called unipotent stem cells.

幹細胞又可依來源分為胚胎幹細胞(embryonic stem cells,ESCs)和成體幹細胞(adult stem cells)。胚胎幹細胞通常是指來自囊胚內細胞團的細胞,成體幹細胞一般係指取自嬰兒出生後的幹細胞。成體幹細胞包括但不限於造血幹細胞(hematopoietic stem cell)、間葉幹細胞、神經幹細胞(neural stem cells,NSCs)、肝幹原細胞(oval cell)等。其中間葉幹細胞又依來源包括但不限於骨髓間葉幹細胞(BMSCs)、胎盤幹細胞(placenta-derived mesenchymal stem cells,PDMSCs)、脂肪幹細胞(adipose-derived adult stem cells,ADASs)、牙齦幹細胞(Human gingival fibroblasts,HGF)等等。Stem cells can be further divided into embryonic stem cells (ESCs) and adult stem cells according to sources. Embryonic stem cells generally refer to cells derived from the inner cell mass of the blastocyst, and adult stem cells generally refer to stem cells taken from the baby's birth. Adult stem cells include, but are not limited to, hematopoietic stem cells, mesenchymal stem cells, neural stem cells (NSCs), hepatic stem cells (oval cells), and the like. Among them, mesenchymal stem cells include but are not limited to bone marrow mesenchymal stem cells (BMSCs), placenta-derived mesenchymal stem cells (PDMSCs), adipose-derived adult stem cells (ADASs), and gingival stem cells (Human gingival). Fibroblasts, HGF) and more.

胚胎幹細胞具有無限次的複製能力和多潛能性的分化潛能,然而其臨床應用上卻有許多待克服的問題,例如道德上的爭議以及移植時會產生免疫排斥等等。成體幹細胞則因臨床上多採自體移植的應用方式,可避免移植時產生免疫排斥的問題及道德上的爭議之優點,然而成體幹細胞也因分裂次數有限,通常僅能分化成少數幾種細胞,如神經幹細胞經適當的條件下可分化為神經元(neurons)、星狀膠質細胞(astrocytes)以及寡樹突膠質細胞(oligodendrocytes),且成體幹細胞在體外增殖培養過程中,常會產生不易維持分化活性及功能性的問題。Embryonic stem cells have unlimited replication ability and pluripotency differentiation potential. However, there are many problems to be overcome in clinical application, such as moral controversy and immune rejection during transplantation. Adult stem cells can avoid the problem of immune rejection and the moral controversy during transplantation because of the clinical application of autologous transplantation. However, adult stem cells are usually only able to differentiate into a few due to limited number of divisions. Seed cells, such as neural stem cells, can be differentiated into neurons (neurons), astrocytes, and oligodendrocytes under appropriate conditions, and adult stem cells are often produced during in vitro proliferation and culture. It is difficult to maintain the problem of differentiation activity and functionality.

另一方面,一般習知適合培養幹細胞的材料以聚苯乙烯(polystyrene)、明膠(gelatin)、聚-α-羥基酸、聚乳酸乙醇酸等,其具有穩定生物適應性的優點,但該些材料用於成體幹細胞的增殖培養過程,有不易分化及或喪失功能的缺點,影響成體幹細胞增殖分化的成效。On the other hand, it is generally known that materials suitable for culturing stem cells are polystyrene, gelatin, poly-α-hydroxy acid, polylactic acid glycolic acid, etc., which have the advantages of stable biocompatibility, but these The material is used for the proliferating culture process of adult stem cells, has the disadvantage of being difficult to differentiate or losing function, and affects the effect of adult stem cell proliferation and differentiation.

目前研究已發現細胞形態可調節幹細胞治療前分化因子的譜系,而球體的細胞形態已被證實與分化潛能有關,例如胚胎幹細胞聚集的群落自緊密的細胞-細胞接觸可以細胞自我更新;胚胎體(Embryoid bodies,EB)為胚胎幹細胞三度空間細胞聚集,可在模擬的正常胚胎生長環境下初始分化,但目前仍未有成體幹細胞聚集為球體之有效方法。At present, it has been found that cell morphology can regulate the lineage of differentiation factors of stem cell treatment, and the cell morphology of the sphere has been confirmed to be related to the differentiation potential. For example, the colony of embryonic stem cells can self-renew from cell-cell contact; embryo body ( Embryoid bodies (EB) are three-dimensional spatial cell aggregation of embryonic stem cells, which can be initially differentiated under the simulated normal embryo growth environment. However, there is still no effective method for adult stem cells to aggregate into spheres.

為解決習知成體幹細胞體外培養不易維持幹性(stemness)及分化之問題,本發明之目的係提供一種使成體幹細胞產生為一球體細胞群體的方法,包含體外培養成體幹細胞於一生物相容性高分子形成的一薄膜上,其中該生物相容性高分子係為幾丁聚醣、褐藻酸鹽、透明質酸、聚己內酯、銀耳多醣或其任一組合;以及收集由成體幹細胞聚集成之一球體細胞群體,其中該球體細胞群體會擴大且具有自我更新及分化為一體細胞的能力;該成體幹細胞選自由神經幹細胞、神經前驅細胞、脂肪幹細胞、牙齦幹細胞、骨髓間葉幹細胞、肺幹細胞及胎盤幹細胞所組成之群組,而生物相容性高分子可為幾丁聚醣與透明質酸的組合,且幾丁聚醣與透明質酸的比例(w/w)約為3/0.177至3/4.425,因本發明使用0.1mg/cm2 ,0.5mg/cm2 ,2.5 mg/cm2 ,因為一個玻片1.77 cm2 ,所以是3 mg(chitosan):0.177mg(HA),3 mg(chitosan):0.885 mg(HA),3 mg(chitosan):4.425 mg(HA)都有效,是利用透明質酸負電吸附在幾丁醣(正電)表面的雙層材料,否則透明質酸抓不住表面會溶到水中,該體細胞可為一神經細胞。另一方面,由成體幹細胞產生的該球體細胞群體進一步具有轉分化(transdifferentiation)為一心肌細胞或一軟骨細胞的能力,其中當該球體細胞群體為脂肪幹細胞時,使脂肪幹細胞與5-azacytidine接觸會轉分化為心肌細胞;而當該球體細胞群體為牙齦幹細胞、脂肪幹細胞、或胎盤幹細胞時,使前述細胞與一轉型生長因子β3(TGF-β3)接觸會轉分化為軟骨細胞。In order to solve the problem that conventional adult stem cells are difficult to maintain stemness and differentiation in vitro, the object of the present invention is to provide a method for producing adult stem cells into a spheroid cell population, comprising culturing adult stem cells in vitro to be compatible with one organism. a film formed by a polymer, wherein the biocompatible polymer is chitosan, alginate, hyaluronic acid, polycaprolactone, tremella polysaccharide or any combination thereof; and collected by adult The stem cells aggregate into a population of spheroid cells, wherein the spheroid cell population expands and has the ability to self-renew and differentiate into a single cell; the adult stem cells are selected from the group consisting of neural stem cells, neural precursor cells, adipose stem cells, gingival stem cells, and mesenchymal stem cells. A group consisting of stem cells, lung stem cells, and placental stem cells, and the biocompatible polymer can be a combination of chitosan and hyaluronic acid, and the ratio of chitosan to hyaluronic acid (w/w) is about It is 3/0.177 to 3/4.425, and 0.1 mg/cm 2 , 0.5 mg/cm 2 , 2.5 mg/cm 2 is used for the present invention, because a slide of 1.77 cm 2 is 3 mg (chitosan): 0.177 mg ( HA) 3 mg (chitosan): 0.885 mg (HA), 3 mg (chitosan): 4.425 mg (HA) are effective, and are double-layered materials that are negatively adsorbed on the surface of chitosan (positive) by hyaluronic acid, otherwise transparent The acid can't catch the surface and dissolve into the water. The somatic cell can be a nerve cell. In another aspect, the population of spheroid cells produced by adult stem cells further has the ability to transdifferentiation into a cardiomyocyte or a chondrocyte, wherein when the spheroid cell population is adipose stem cells, the adipose stem cells are incubated with 5-azacytidine. The contact is transdifferentiated into cardiomyocytes; and when the spheroid cell population is gingival stem cells, adipose stem cells, or placental stem cells, the cells are transdifferentiated into chondrocytes by contact with a transforming growth factor β3 (TGF-β3).

本發明之另一目的為提供一種具有分化能力的成體幹細胞,係由以下方法所製成,包含使一成體幹細胞與一生物相容性高分子形成的一薄膜接觸一段有效時間,其中該生物相容性高分子係為幾丁聚醣、褐藻酸鹽、透明質酸或其任一組合;其中該成體幹細胞會形成一球體細胞群體,該球體細胞群體會擴大並具有轉分化為一軟骨細胞或一心肌細胞的能力;該成體幹細胞選自由神經幹細胞、神經前驅細胞、脂肪幹細胞、牙齦幹細胞、及胎盤幹細胞所組成之群組,而生物相容性高分子可進一步包含一具有如SEQ ID NO:1胺基酸序列之纖維素結合功能區域-RGD貼附序列(cellulose binding domain-RGD,CBD-RGD)能提昇球體細胞群體的轉分化能力;生物相容性高分子或可為幾丁聚醣與透明質酸的組合,且幾丁聚醣與透明質酸的比例約為3:0.177至3:4.425(w/w);可為幾丁聚醣與銀耳多醣的組合,且幾丁聚醣與銀耳多醣的比例約為3:0.4至3:4.5(w/w);亦可為聚己內酯與透明質酸的組合;該體細胞可為一神經細胞。Another object of the present invention is to provide an adult stem cell having differentiation ability, which is prepared by contacting an adult stem cell with a film formed of a biocompatible polymer for an effective period of time, wherein The biocompatible polymer is chitosan, alginate, hyaluronic acid or any combination thereof; wherein the adult stem cells form a spheroid cell population, and the spheroid cell population expands and has a transdifferentiation into one The ability of a chondrocyte or a cardiomyocyte; the adult stem cell is selected from the group consisting of a neural stem cell, a neural precursor cell, a fat stem cell, a gingival stem cell, and a placental stem cell, and the biocompatible polymer may further comprise a The cellulose binding functional region of the amino acid sequence of SEQ ID NO: 1 - RGD attachment sequence (MSC binding domain-RGD, CBD-RGD) can enhance the transdifferentiation ability of the spheroid cell population; the biocompatible polymer may be a combination of chitosan and hyaluronic acid, and the ratio of chitosan to hyaluronic acid is about 3:0.177 to 3:4.425 (w/w); it can be chitosan and tremella polysaccharide Combination, and the ratio of chitosan to tremella polysaccharide is about 3:0.4 to 3:4.5 (w/w); it can also be a combination of polycaprolactone and hyaluronic acid; the somatic cell can be a nerve cell .

本發明之又一目的為提供一種醫藥組合物,包含前述之成體幹細胞及一藥學上可接受載體。載體可為賦形劑(如水)、填充劑(如蔗糖或澱粉)、黏合劑(如纖維素衍生物)、稀釋劑、崩解劑、吸收促進劑或甜味劑,但並未僅限於此。本發明醫藥組成物可依一般習知幹細胞療法藥劑之製備方法生產製造,將本發明成體幹細胞與一種以上之載體相混合,製備出所需之劑型,此劑型可包括錠劑、粉劑、粒劑、膠囊或其他液體製劑,但未以此為限。本發明的醫藥組合物可應用於臨床上幹細胞療法,以促進神經細胞、心肌細胞或軟骨細胞的再生,亦可藉此包含成體幹細胞的醫藥組合物來避免胚胎幹細胞取得不易及倫理上的考量。It is still another object of the present invention to provide a pharmaceutical composition comprising the aforementioned adult stem cells and a pharmaceutically acceptable carrier. The carrier may be, but is not limited to, an excipient such as water, a filler such as sucrose or starch, a binder such as a cellulose derivative, a diluent, a disintegrant, an absorption enhancer or a sweetener. . The pharmaceutical composition of the present invention can be produced according to a conventional method for preparing a stem cell therapy agent, and the adult stem cells of the present invention are mixed with one or more carriers to prepare a desired dosage form, which can include a tablet, a powder, and a tablet. Agents, capsules or other liquid preparations, but not limited to this. The pharmaceutical composition of the present invention can be applied to clinical stem cell therapy to promote regeneration of nerve cells, cardiomyocytes or chondrocytes, and the pharmaceutical composition comprising adult stem cells can be used to avoid the difficulty and ethical consideration of embryonic stem cells. .

本發明之優點為提供一新穎的哺乳動物多能成體幹細胞、其醫藥組合物、以及用於生產該成體幹細胞的方法,係藉由生物相容性高分子接觸而達到自我更新及維持幹性(stemness)的突出效果。An advantage of the present invention is to provide a novel mammalian pluripotent adult stem cell, a pharmaceutical composition thereof, and a method for producing the same, which are self-renewing and maintaining dryness by contact with a biocompatible polymer. (stemness) outstanding effect.

以下將配合圖式進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明,並非用以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。The embodiments of the present invention are further described in the following description, and the embodiments of the present invention are set forth to illustrate the present invention, and are not intended to limit the scope of the present invention. In the scope of the invention, the scope of protection of the invention is defined by the scope of the appended claims.

本發明實施例使用的天然生物相容性高分子為幾丁聚醣、褐藻酸鹽、透明質酸或其任一組合,其中幾丁聚醣(chitosan)由胺基多醣類(amino-polysaccharide)所組成,幾丁聚醣包含與細胞外間質相同成分的葡萄糖胺多醣(glycosamino-glycan),所以生物相容性高且為生物可分解的材料。褐藻酸鹽(alginate)為一可增進神經軸突再生的天然軟質聚合物,褐藻酸鹽可在生理條件(於室溫或是體溫、生理pH值以及等滲透壓)下與鈣離子交聯;褐藻酸鈣(calcium alginate)為一生物可相容性和無致免疫性,所以為高穩定性以及高生物相容性的材料。透明質酸(hyaluronic acid,HA)可增進細胞遷移(migration)、增殖以及間質分泌的材料,且為水溶性不會形成薄膜,在本發明中是與幾丁聚糖組合形成一薄膜。因此,本發明係揭露前述生物相容性高分子應用於成體幹細胞培養的新穎方法。The natural biocompatible polymer used in the embodiment of the present invention is chitosan, alginate, hyaluronic acid or any combination thereof, wherein chitosan is composed of amino-polysaccharide. The chitosan comprises a glycosamino-glycan which is the same component as the extracellular matrix, and is therefore biocompatible and biodegradable. Alginate is a natural soft polymer that promotes axon regeneration. Alginate can be cross-linked with calcium ions under physiological conditions (at room temperature or body temperature, physiological pH and isotonic pressure); Calcium alginate is a biocompatible and non-immunogenic material, so it is a material with high stability and high biocompatibility. Hyaluronic acid (HA) is a material that promotes cell migration, proliferation, and interstitial secretion, and does not form a film when it is water-soluble. In the present invention, it is combined with chitosan to form a film. Accordingly, the present invention discloses a novel method of applying the aforementioned biocompatible polymer to adult stem cell culture.

本發明實施例使用的成體幹細胞為神經幹細胞、神經前驅細胞、脂肪幹細胞、牙齦幹細胞、及胎盤幹細胞,經與前述的生物相容性高分子形成之薄膜接觸,會使該些成體幹細胞聚集形成一球體細胞群體,且本發明的球體細胞群體以胰蛋白酶(trypsin)處理是會整粒球由薄膜上脫離,若只是先前文獻提及的幹細胞聚集現象,用胰蛋白酶(trypsin)處理是一顆一顆細胞分開脫離。The adult stem cells used in the embodiments of the present invention are neural stem cells, neural precursor cells, adipose stem cells, gingival stem cells, and placental stem cells, which are brought into contact with a film formed by the aforementioned biocompatible polymer, which causes the adult stem cells to aggregate. Forming a population of spheroid cells, and treating the population of spheroid cells of the present invention with trypsin detaches the globules from the membrane. If only the stem cell aggregation phenomenon mentioned in the prior literature is treated with trypsin One cell separates.

本發明的各實施例中,實施例1及2為利用不同分子量的幾丁聚醣和不同M/G比的褐藻酸鹽製成二度空間(2D)薄膜,比較神經幹細胞培養於其上和其他習知材料(ex.TCPS)之形態及分化結果比較。實施例3-5為利用不同分子量的幾丁聚醣、改質之幾丁聚醣、或與透明質酸結合的幾丁聚醣膜分別培養脂肪幹細胞、牙齦幹細胞、包皮纖維母細胞或是胎盤幹細胞,與培養於其他習知材料(ex.TCPS)之形態以及分化結果比較。實施例6為利用幾丁聚醣-銀耳多醣培養脂肪幹細胞與神經幹細胞,觀察其形態。In each of the embodiments of the present invention, Examples 1 and 2 are two-dimensional (2D) films made by using chitosan of different molecular weights and alginate of different M/G ratios, and comparing neural stem cells culture thereon. Comparison of the morphology and differentiation results of other conventional materials (ex. TCPS). Example 3-5 is to culture adipose stem cells, gingival stem cells, foreskin fibroblasts or placenta by using chitosan of different molecular weight, modified chitosan, or chitosan membrane combined with hyaluronic acid. Stem cells were compared with the morphology of cultured other known materials (ex. TCPS) and differentiation results. Example 6 was to culture adipose stem cells and neural stem cells with chitosan-white fungus polysaccharide, and observe the morphology thereof.

本發明之一實施例係藉由分析神經幹細胞及神經前驅細胞在不同材料上之型態與分化,判斷其自我更新及幹性維持與否;其中不同材料係以去乙醯度、表面電位、及水接觸角分析各材料產生出球體細胞群體的效果。進一步並確認球體細胞群體的細胞型態以及分化的效果,其中F1B-螢光綠蛋白(F1B-GFP)在未分化的神經幹細胞會表現出綠色螢光,因此神經幹細胞分化的分析係偵測F1B-螢光綠蛋白的表現,進而配合免疫螢光偵測神經幹細胞的標記nestin及未發育完全神經元的標記β3-tubulin。One embodiment of the present invention determines the self-renewal and dryness maintenance of neural stem cells and neural precursor cells on different materials, and the different materials are de-acetylated, surface potential, And water contact angle analysis of each material produces a spherical cell population effect. Further confirming the cell type and differentiation effect of the spheroid cell population, wherein F1B-fluorescent green protein (F1B-GFP) exhibits green fluorescence in undifferentiated neural stem cells, so the analysis of neural stem cell differentiation detects F1B. - The expression of fluorescein, which in turn is combined with immunofluorescence to detect the labeled nestin of neural stem cells and the marker β3-tubulin of undeveloped neurons.

在本發明中所使用者,”一神經幹細胞”或"一神經前驅細胞”係指未分化的中樞神經(CNS)多能幹細胞。In the present invention, "a neural stem cell" or "a neural precursor cell" refers to an undifferentiated central nervous system (CNS) pluripotent stem cell.

“一具有分化能力的成體幹細胞”係指一成體幹細胞容易分化為多種類的體細胞。依照本發明的方法處理成體幹細胞,能使成體幹細胞具有自我更新及分化的能力,提升成體幹細胞的可塑性。"An adult stem cell with differentiation ability" refers to a body cell in which an adult stem cell is easily differentiated into a plurality of types. The treatment of adult stem cells in accordance with the method of the present invention enables adult stem cells to self-renew and differentiate and enhance the plasticity of adult stem cells.

“一段有效時間”係指生物相容性高分子與本發明的成體幹細胞形成一球體細胞群體所必需的一段時間,例如神經幹細胞與幾丁聚糖接觸一段時間使其聚集形成球體。關於與生物相容性高分子接觸的一段有效時間,在本說明書中可為4個小時到14日或更多,較佳為1日到4日。By "a period of effective time" is meant a period of time necessary for the biocompatible macromolecule to form a spheroid cell population with the adult stem cells of the invention, for example, the neural stem cells are contacted with chitosan for a period of time to agglomerate to form a sphere. The effective period of contact with the biocompatible polymer may be from 4 hours to 14 days or more, preferably from 1 day to 4 days in the present specification.

“一藥學上可接受載體”係指用於達成或增進本發明醫藥組合物成功遞送的物質,可為賦形劑(如水)、填充劑(如蔗糖或澱粉)、黏合劑(如纖維素衍生物)、稀釋劑、崩解劑、吸收促進劑或甜味劑,但並未僅限於此。"A pharmaceutically acceptable carrier" means a substance used to achieve or enhance the successful delivery of a pharmaceutical composition of the invention, which may be an excipient (such as water), a filler (such as sucrose or starch), a binder (such as cellulose derived). But not limited to this, a diluent, a disintegrant, an absorption enhancer or a sweetener.

“約”、”約略”或”近似地”一般係指20%,較佳為10%,最佳為5%的範圍內。本文中的數值係為近似值,在未明確定義的情況下可隱含「約」「約略」或「近似地」之含義。"About", "about" or "approximately" generally means within 20%, preferably 10%, and most preferably 5%. Numerical values herein are approximate and may imply the meaning of "about" or "approximately" if not explicitly defined.

“一”係指一個或一個以上(即是至少一個)的冠詞文法受詞。舉例而言,“一細胞”係指一個細胞或一個以上的細胞。"一" means one or more (ie, at least one) grammatical vocabulary. For example, "a cell" refers to one cell or more than one cell.

本發明實施例中測量生物相容性高分子表面電位之分析方法,準備4 cm×1.5 cm的薄膜,利用表面電位分析儀(Beckman Coulter)測其表面電位(mV,Surface zeta potential)。In the embodiment of the present invention, a method for measuring the surface potential of a biocompatible polymer was prepared, and a film of 4 cm × 1.5 cm was prepared, and a surface potential (mV, Surface zeta potential) was measured by a surface potential analyzer (Beckman Coulter).

本發明實施例所用之神經幹細胞免疫螢光染色方法,為量測幾丁聚醣膜上神經幹細胞球的分化狀態,細胞標記(nestin,標記於神經幹細胞;β3-tubulin,標記於神經元)用於免疫螢光染色。在細胞培養不同週期時間被固定於4%仲甲醛(paraformaldehyde)中。以磷酸鹽緩衝液潤洗三次。加入0.5% Triton X-100(t-octylphenoxypolyethoxyethanol,Sigma,USA)500μl 10分鐘以破壞細胞膜及核膜。以磷酸鹽緩衝液潤洗樣本幾次,加入20μl一級抗體於暗室37℃培養置放1小時。為將細胞染色,加入0.1%之4,6-聯脒-3-苯吲哚二鹽酸鹽(4,6-diamidino-2-phenylindole dihydrochloride)(購於DAPI,Sigma,D9542,USA)200μl於暗室30分鐘。最後,潤洗樣本後將其架於顯微鏡載玻片上,以甘油凝膠密封。樣本於正立式螢光顯微鏡觀察(購於Nikon,80i)。一級抗體稀釋比例如下:anti-nestin(R-20) goat-poly IgG抗體(購於Santa Cruz,USA;1:1000)以及anti-β3-tublin mouse-mono IgG(購於Santa Cruz,USA;1:1000)。二級抗體稀釋比例為FITC-conjugated goat anti-mouse IgG(以馬血清蛋白稀釋;1:100;購於Chemicon,CA)以及goat anti-rabbit IgG-horeseradish peroxidase(HRP)(購於Santa Cruz,USA;1:100)。The neural stem cell immunofluorescence staining method used in the embodiments of the present invention is for measuring the differentiation state of neural stem cell spheres on the chitosan membrane, and the cell marker (nestin, labeled with neural stem cells; β3-tubulin, labeled with neurons) Immunofluorescence staining. It was fixed in 4% paraformaldehyde at different cycle times of cell culture. Rinse three times with phosphate buffer. 0.5 μ Triton X-100 (t-octylphenoxypolyethoxyethanol, Sigma, USA) 500 μl was added for 10 minutes to destroy the cell membrane and nuclear membrane. The sample was rinsed several times with phosphate buffer, and 20 μl of the primary antibody was added and cultured in a dark room at 37 ° C for 1 hour. To stain the cells, add 0.1% of 4,6-diamidino-2-phenylindole dihydrochloride (purchased in DAPI, Sigma, D9542, USA) to 200 μl. Dark room for 30 minutes. Finally, the sample was rinsed and placed on a microscope slide and sealed with glycerin gel. The sample was observed under an upright fluorescent microscope (purchased from Nikon, 80i). The dilution ratio of the primary antibody was as follows: anti-nestin (R-20) goat-poly IgG antibody (purchased from Santa Cruz, USA; 1:1000) and anti-β3-tublin mouse-mono IgG (purchased from Santa Cruz, USA; :1000). The dilution ratio of the secondary antibody was FITC-conjugated goat anti-mouse IgG (diluted with horse serum albumin; 1:100; purchased from Chemicon, CA) and goat anti-rabbit IgG-horeseradish peroxidase (HRP) (purchased from Santa Cruz, USA). ; 1:100).

本發明實施例對於心肌分化能力的分析係利用正立螢光顯微鏡(NIKON):樣品以磷酸鹽緩衝液潤洗,加入4% paraformaldehyde室溫下固定20分鐘,以磷酸鹽緩衝液清洗3次,每次10分鐘,加入3% BSA/磷酸鹽緩衝液室溫下30分鐘後,吸出,加入3% BSA配製的一抗,稀釋倍率為下表,以parafilm封住後放入4℃冰箱過夜;隔天,將一抗吸出,以磷酸鹽緩衝液潤洗三次(以下步驟全程避光),加入3% BSA配製的二抗,以鋁箔紙蓋住避光後放入37℃培養箱1小時;將二抗吸出,磷酸鹽緩衝液潤洗三次,加入3% BSA配製的DAPI染劑3分鐘,吸出,磷酸鹽緩衝液清洗三次後,加入磷酸鹽緩衝液,利用針頭與夾子將材料從24孔培養板取出,放置於載玻片上以正立螢光顯微鏡(購於NIKON)觀察之。The analysis of myocardial differentiation ability of the examples of the present invention utilizes an erect fluorescent microscope (NIKON): the sample is rinsed with a phosphate buffer solution, fixed at room temperature for 20 minutes by adding 4% paraformaldehyde, and washed three times with phosphate buffer. After 10 minutes, add 3% BSA/phosphate buffer for 30 minutes at room temperature, aspirate, add 3% BSA prepared primary antibody, the dilution ratio is the following table, sealed with parafilm and placed in a refrigerator at 4 ° C overnight; The next day, the primary antibody was aspirated and rinsed three times with phosphate buffer solution (the following steps were protected from light throughout the whole process), and the secondary antibody prepared with 3% BSA was added, covered with aluminum foil paper and protected from light, and placed in a 37 ° C incubator for 1 hour; The secondary antibody was aspirated, phosphate buffer was rinsed three times, DAC dye prepared with 3% BSA was added for 3 minutes, aspirated, phosphate buffer was washed three times, phosphate buffer was added, and the material was removed from the well by needle and clip. The plate was taken out and placed on a glass slide and observed with a erect fluorescent microscope (purchased from NIKON).

本發明實施例所分析細胞表面蛋白特徵,係使用之流式細胞儀分析方法,利用流式細胞儀(購於FACScan,BD,USA)。首先,將細胞從培養盤上取下來,取5×105 cells/ml以磷酸鹽緩衝液清洗,以1000rpm離心5分鐘,重複三次後收集細胞,加入100μl磷酸鹽緩衝液回溶細胞後,在細胞液中加入10μl一抗,反應30~60分鐘,磷酸鹽緩衝液潤洗三次後,避光下加入10μl二抗反應30~60分鐘,以磷酸鹽緩衝液清洗,1000 rpm離心5分鐘,重複三次以移除未反應之抗體,最後加入500μl磷酸鹽緩衝液回溶細胞,即可移至流式細胞儀進行分析。The cell surface protein characteristics analyzed in the examples of the present invention were analyzed by flow cytometry using a flow cytometer (purchased from FACScan, BD, USA). First, the cells were removed from the culture plate, washed at 5 × 10 5 cells/ml in phosphate buffer, centrifuged at 1000 rpm for 5 minutes, and the cells were collected three times, and 100 μl of phosphate buffer was added to reconstitute the cells. Add 10 μl of primary antibody to the cell solution, react for 30 to 60 minutes, rinse with phosphate buffer three times, add 10 μl of secondary antibody for 30 to 60 minutes in the dark, wash with phosphate buffer, centrifuge at 1000 rpm for 5 minutes, repeat Three times to remove unreacted antibody, and finally 500 μl of phosphate buffer was added to re-dissolve the cells, and then transferred to a flow cytometer for analysis.

前述該些分析結果係以平均值±標準差表示之,並使用t檢定(t-test)作統計數據分析,當p值小於0.05則具有統計上意義的差異性。The above analysis results are expressed as mean ± standard deviation, and t-test is used for statistical analysis. When the p value is less than 0.05, there is a statistically significant difference.

以下,本發明將結合各種實例詳細敘述。這些實例僅提供作為例示目的,並非推斷本發明限於這些實例。另外,儘管在實例中例示成體幹細胞中的神經幹細胞、神經前驅細胞及脂肪幹細胞自鼠分離而來;牙齦幹細胞、胎盤幹細胞自人類分離而來,但本發明不可侷限於此,而是可應用於自包含人類、大鼠、小鼠及猴等哺乳類動物分離而來者。Hereinafter, the present invention will be described in detail in conjunction with various examples. These examples are provided for illustrative purposes only and are not intended to limit the invention to these examples. In addition, although the neural stem cells, the neural precursor cells, and the adipose stem cells in the adult stem cells are exemplified in the examples, the gingival stem cells and the placental stem cells are isolated from humans, but the present invention is not limited thereto, but is applicable. It is isolated from mammals including humans, rats, mice and monkeys.

實施例1Example 1

以二種分子量之幾丁聚醣薄膜培養成體神經幹細胞/神經前驅細胞Culture of adult neural stem cells/neural precursor cells with chitosan films of two molecular weights

1.1 幾丁聚醣薄膜製備1.1 Preparation of chitosan film

利用二種幾丁聚醣-1(購於Fluka,USA)及幾丁聚醣-2(購於Sigma,USA)各自配製濃度為1%的幾丁聚醣,係秤取0.5g幾丁聚醣粉末溶入於49.5ml二次水,室溫下攪拌半小時後加入0.5ml乙酸,並於室溫中輕拌12小時。隔天使用濾網過濾雜質即為1%幾丁聚醣溶液,其中幾丁聚醣-1的分子量約為510kDa,幾丁聚醣-2的分子量約為400kDa。將所得溶液以100μm的網目過濾,再塗佈於玻璃蓋玻片上(每片直徑15mm玻片塗佈100μl溶液),並晾乾兩天。將幾丁聚醣膜浸入0.5N NaOH溶液中5分鐘,再以蒸餾去離子水大面積潤洗直到薄膜附近的水之酸鹼值達到中性(neutral)。最後,將該幾丁聚醣膜充分晾乾。Two chitosan-1 (purchased from Fluka, USA) and chitosan-2 (purchased from Sigma, USA) were used to prepare chitosan at a concentration of 1%, and 0.5 g of chitosan was weighed. The sugar powder was dissolved in 49.5 ml of secondary water, stirred at room temperature for half an hour, and then 0.5 ml of acetic acid was added, and the mixture was gently stirred at room temperature for 12 hours. The filter was used to filter impurities on the next day as a 1% chitosan solution, wherein the chitosan-1 has a molecular weight of about 510 kDa and the chitosan-2 has a molecular weight of about 400 kDa. The resulting solution was filtered through a mesh of 100 μm, and then coated on a glass coverslip (100 μl of each 15 mm diameter slide) and allowed to air dry for two days. The chitosan membrane was immersed in a 0.5 N NaOH solution for 5 minutes, and then rinsed with distilled deionized water over a large area until the pH of the water near the film reached a neutral state. Finally, the chitosan film was sufficiently dried.

1.2 鼠腦神經幹細胞萃取及培養1.2 Rat brain neural stem cell extraction and culture

由基因轉殖鼠含啟動子F1B-螢光綠蛋白(F1B-GFP)基因的腦部分離出神經幹細胞。兩個月大的小白鼠整個腦部絞碎再輕磨成更小碎塊,取得單一細胞懸浮液。絞碎的細胞植入35-mm無補充基質和附著力因子的培養皿中,以DMEM/F-12培養基(Dulbecco’s modified Eagle’s medium and Ham’s F-12,購於Giboco,USA) 1:1培養液含10%胎牛血清(fetal bovine serum,FBS)(購於Gibco,USA)。兩天後,每個培養皿有將近10-20個細胞進行細胞分裂。以胰蛋白酶處理後將其集中,並繼續培養2-3天。進一步用由200μg/ml的糖甘類抗生素geneticin(G418,購於Gibco)挑選出穩定的細胞系(cell line)。以流式細胞儀(FACS Aria,購於BD Biosciences)重複純化GFP-陽性的鼠腦細胞至純度達95%以上。Neural stem cells were isolated from the brain of a gene-transforming mouse containing the promoter F1B-fluorescence green protein (F1B-GFP) gene. The two-month-old mouse was ground and shredded into smaller pieces to obtain a single cell suspension. The minced cells were implanted in a 35-mm culture dish containing no supplemental matrix and adhesion factor in DMEM/F-12 medium (Dulbecco's modified Eagle's medium and Ham's F-12, purchased from Giboco, USA) 1:1 medium. Contains 10% fetal bovine serum (FBS) (purchased from Gibco, USA). After two days, nearly 10-20 cells per cell were subjected to cell division. After trypsin treatment, concentrate them and continue to culture for 2-3 days. A stable cell line was further selected with 200 μg/ml of glycoside antibiotic geneticin (G418, available from Gibco). The GFP-positive mouse brain cells were repeatedly purified by flow cytometry (FACS Aria, purchased from BD Biosciences) to a purity of 95% or more.

1.3 神經幹細胞/神經前驅細胞於幾丁聚醣薄膜之形態分析與分化為神經細胞的情形1.3 Morphological analysis and differentiation of neural stem cells/neural precursor cells into chitosan membranes

將神經幹細胞植入培養材料前,玻璃蓋玻片上之幾丁聚醣膜浸於75%乙醇,再以磷酸鹽緩衝液(phosphate buffered saline,PBS)潤洗,然後放進24孔培養板的每一孔中。神經幹細胞植入密度為每孔5×104 個細胞。用DMEM/F-12培養基添加10%的胎牛血清(購於Gibco,USA),400μg/ml糖甘類抗生素(G418)以及鏈黴素-青黴素(100U/ml)作為培養液。培養於溫度37℃,5% CO2 的加濕培養箱,每週更換培養液兩次;另外並以未加生長因子的聚苯乙烯組織培養板(tissue culture polystyrene surface,TCPS)及明膠(gelatin)作為對照組,結果如第一圖及第二圖所示。Before implanting the neural stem cells into the culture material, the chitosan membrane on the glass coverslip was immersed in 75% ethanol, rinsed with phosphate buffered saline (PBS), and then placed in a 24-well culture plate. In a hole. Neural stem cells were implanted at a density of 5 x 10 4 cells per well. 10% fetal calf serum (purchased from Gibco, USA), 400 μg/ml glycoside antibiotic (G418), and streptomycin-penicillin (100 U/ml) were added as a culture solution in DMEM/F-12 medium. Incubate in a humidified incubator at 37 ° C, 5% CO 2 , and change the culture medium twice a week; in addition, tissue culture polystyrene surface (TCPS) and gelatin (gelatin) As a control group, the results are shown in the first figure and the second figure.

第一圖顯示神經幹細胞培養於TCPS和明膠上三天的形態,在TCPS和明膠上無觀察到任何細胞聚集,且細胞貼於TCPS和明膠。另一方面,培養於幾丁聚醣薄膜上的細胞在1-2天開始聚集,最終聚集為球狀,剛開始24小時,大部分的細胞形狀為圓形;48小時內多數細胞聚集形成球體。於幾丁聚醣-1上球體的數量和大小皆大致比幾丁聚醣-2還要大(如第二圖所示)。The first panel shows the morphology of neural stem cells cultured on TCPS and gelatin for three days. No cell aggregation was observed on TCPS and gelatin, and the cells were attached to TCPS and gelatin. On the other hand, the cells cultured on the chitosan film began to aggregate in 1-2 days, and eventually aggregated into a globular shape. At the beginning of 24 hours, most of the cells were round in shape; most cells aggregated to form spheres within 48 hours. . The number and size of the spheres on chitosan-1 are roughly larger than that of chitosan-2 (as shown in the second figure).

為確認本發明實施例所產生之球體為三度空間的立體球體而不只是聚集,由第三圖的掃描式電子顯微影像,球體的側視圖可清楚顯示其三度結構,而由光學影像顯示球體大小隨著時間增加,可達約100μm。In order to confirm that the sphere produced by the embodiment of the present invention is a three-dimensional space of a three-dimensional sphere instead of just gathering, by the scanning electron microscopic image of the third figure, the side view of the sphere can clearly show the three-dimensional structure, and the optical image The size of the sphere is shown to increase over time, up to about 100 μm.

另外,第四至六圖則顯示神經幹細胞的分化程度。神經幹細胞的螢光強度,有綠色螢光顯現表示未分化。綠色螢光在15天之後開始消退,但仍然清晰(如第四圖6d所示)。在15天時,一些細胞開始從球內移出,因此,神經幹細胞球體的大小改變相當快速,而移出的細胞未顯現任何綠色螢光。球體在15天後螢光消沒除了顯示細胞的移出外,球體內的細胞也已經分化。In addition, the fourth to sixth graphs show the degree of differentiation of neural stem cells. The fluorescence intensity of neural stem cells, with green fluorescence, indicates undifferentiation. The green fluorescence began to fade after 15 days, but it remained clear (as shown in Figure 6d). At 15 days, some of the cells began to move out of the sphere, so the size of the neural stem cell spheres changed quite rapidly, and the removed cells did not show any green fluorescence. Fluorescence elimination of the sphere after 15 days In addition to showing the removal of cells, the cells in the sphere have also differentiated.

在免疫螢光染色試驗上,神經幹細胞的標示蛋白培養於幾丁聚醣-1的表示第五圖所示(nestin)和第六圖所示(β3-tubulin)。發現球體在21天時仍強烈顯示具有nestin陽性,顯示球體的細胞可維持神經幹細胞狀態達21天;Nestin的顯示在培養時間增加時些微降低。另一方面,整個過程中β3-tubulin的表現皆低。此結果顯示神經幹細胞培養於幾丁聚醣薄膜上可為一維持這些細胞自我更新能力和幹性(stemness)的方法,或用於自細胞群中純化神經幹細胞。In the immunofluorescence staining assay, the marker protein of neural stem cells cultured in chitosan-1 is shown in the fifth panel (nestin) and in the sixth panel (β3-tubulin). The spheres were found to be strongly positive for nestin at 21 days, indicating that the cells of the sphere maintained the state of the neural stem cells for 21 days; the display of Nestin showed a slight decrease as the incubation time increased. On the other hand, the performance of β3-tubulin was low throughout the process. This result shows that the cultivation of neural stem cells on the chitosan film can be a method of maintaining the self-renewal ability and stemness of these cells, or for purifying neural stem cells from a cell population.

1.4 幾丁聚醣和組織培養板(TCPS)之去乙醯度、表面電位,以及水接觸角值列於表1。1.4 Deacetylation, surface potential, and water contact angle values for chitosan and tissue culture plates (TCPS) are listed in Table 1.

表1不同的幾丁聚醣(幾丁聚醣-1(CS-1)和幾丁聚醣-2(CS-2))和組織培養板(TCPS)特性比較(a)去乙醯度(b)表面電位,和(c)表面水接觸角。Table 1 Comparison of characteristics of different chitosan (chitosan-1 (CS-1) and chitosan-2 (CS-2)) and tissue culture plates (TCPS) (a) deacetylation degree ( b) surface potential, and (c) surface water contact angle.

幾丁聚醣-1、幾丁聚醣-2的去乙醯度分別約為77.7%、86.0%。幾丁聚醣去乙醯度值越高,表面水接觸角越低,親水性越高,即親水性幾丁聚醣-2大於幾丁聚醣-1,而兩者幾丁聚醣表面親水性皆高於TCPS,因細胞在親水性高的基質中較容易貼附,神經幹細胞貼附於TCPS上比幾丁聚醣上來得好。而且,神經幹細胞在幾丁聚醣-2上的貼附比幾丁聚醣-1要好,且在幾丁聚醣-1上球體形成時間延遲。幾丁聚醣的去乙醯度提高,氨基群和分子內的氫鍵會增加,可能造成表面變硬和強結晶性,亦與我們的結果一致。幾丁聚醣-1與幾丁聚醣-2的表面電位皆為負值,但數值接近中性,表面電性較負之表面,在本實施例的結果中,神經幹細胞並沒有貼附得很好而呈現聚集的狀況。幾丁聚醣-1的表面硬度(壓痕深度約50nm)近似於內部(壓痕深度100-150)。另一方面,幾丁聚醣-2之表面硬度高於內部且亦高於幾丁聚醣-1,幾丁聚醣-2較幾丁聚醣-1粗糙且表面上更加密集的晶體結構。因更硬和結晶性更高的表面,神經幹細胞可能貼附於幾丁聚醣-2比幾丁聚醣-1更好且形成的球體較小。The deacetylation degree of chitosan-1 and chitosan-2 was about 77.7% and 86.0%, respectively. The higher the chitosan deacetylation degree, the lower the surface water contact angle, and the higher the hydrophilicity, that is, the hydrophilic chitosan-2 is larger than the chitosan-1, and the surface of the chitosan is hydrophilic. The sex is higher than TCPS, because the cells are easier to attach in a highly hydrophilic matrix, and the neural stem cells are attached to TCPS better than chitosan. Moreover, the attachment of neural stem cells to chitosan-2 was better than that of chitosan-1, and the formation of spheres on chitosan-1 was delayed. The degree of deacetylation of chitosan is increased, and the hydrogen bond in the amino group and the molecule is increased, which may cause surface hardening and strong crystallinity, which is consistent with our results. The surface potentials of chitosan-1 and chitosan-2 were all negative, but the values were close to neutral, and the surface was less negative. In the results of this example, the neural stem cells were not attached. Very good and present a gathering situation. The surface hardness of chitosan-1 (indentation depth of about 50 nm) is similar to the inside (indentation depth 100-150). On the other hand, the surface hardness of chitosan-2 is higher than that of the interior and is also higher than that of chitosan-1, and the chitosan-2 is coarser than the chitosan-1 and has a more dense crystal structure on the surface. Due to the harder and more crystalline surface, neural stem cells may adhere to chitosan-2 better than chitosan-1 and form smaller spheres.

實施例2Example 2

以二種褐藻酸鹽薄膜培養成體神經幹細胞/神經前驅細胞、脂肪幹細胞Culture of adult neural stem cells/neural precursor cells and adipose stem cells with two alginate films

2.1 褐藻酸鹽薄膜製備2.1 Preparation of alginate film

利用兩種褐藻酸鹽製備薄膜,包括較低M/G比(β-D-mannuronic acid/α-L-guluronic acid ratio)的褐藻酸鹽A#1(M/G ratio=0.5,分子量110,000,購於Hayashi,Japan)和較高M/G比的褐藻酸鹽A#2(M/G ratio=1.59,分子量12,000-80,000,Sigma,USA)。褐藻酸鹽A#1及A#2先分別溶於9mg/ml氯化鈉溶液使溶液濃度為40mg/ml。調整溶液pH值至7,以高壓滅菌(125℃以及1.5atm)30分鐘後加入2-[4-(2-羥乙基)哌嗪-1-基]乙磺酸(2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid,購於HEPES,Invitrogen)維持與人體相同的酸鹼值。本發明實施例使用的二種褐藻酸鹽皆可製作成平滑或是有皺褶的膜。褐藻酸鹽薄膜係在每孔加入400μl褐藻酸鹽至24孔培養板(購於Corning,USA),經層流風乾60分鐘再沿孔緣緩慢滴入102mM氯化鈣製備。A film was prepared using two alginate, including alginate A#1 with a lower M/G ratio (β-D-mannuronic acid/α-L-guluronic acid ratio) (M/G ratio=0.5, molecular weight 110,000, Alginate A#2 (M/G ratio=1.59, molecular weight 12,000-80,000, Sigma, USA) purchased from Hayashi, Japan) and higher M/G ratio. Alginate A#1 and A#2 were first dissolved in 9 mg/ml sodium chloride solution to make the solution concentration 40 mg/ml. Adjust the pH of the solution to 7, and autoclave (125 ° C and 1.5 atm) for 30 minutes after adding 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (2-[4-( 2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid, purchased from HEPES, Invitrogen, maintains the same pH value as the human body. Both alginate used in the examples of the present invention can be made into a smooth or wrinkled film. The alginate film was prepared by adding 400 μl of alginate per well to a 24-well culture plate (purchased from Corning, USA), air-dried for 60 minutes, and slowly dropping 102 mM calcium chloride along the edge of the well.

2.2 大鼠脂肪幹細胞(rADASs)之萃取及培養2.2 Extraction and culture of rat adipose stem cells (rADASs)

從大鼠(Spraque-Dawley rate,SD rate)皮下取得脂肪組織,使用磷酸鹽緩衝液清洗,剪成小碎塊,第一次離心(1500 rpm,5 mins)。將上層脂肪倒入新的離心管和加入少許磷酸鹽緩衝液,再盡量剪小塊,進行第二次離心(1500 rpm,5 mins)。取上層脂肪,同時配製消化液:1 mg/ml第一型膠原蛋白脢(collagenase type I,購於Sigma)/HBSS溶液(HBSS緩衝溶液配製如表4)。Adipose tissue was obtained subcutaneously from rats (Spraque-Dawley rate, SD rate), washed with phosphate buffer, cut into small pieces, and centrifuged for the first time (1500 rpm, 5 mins). Pour the upper layer of fat into a new centrifuge tube and add a little phosphate buffer, then cut as much as possible and perform a second centrifugation (1500 rpm, 5 mins). Take the upper layer of fat and prepare the digestive juice: 1 mg/ml collagen type I (collagenase type I, purchased from Sigma) / HBSS solution (HBSS buffer solution is prepared as shown in Table 4).

表4 HBSS緩衝溶液成分Table 4 HBSS buffer solution components

將脂肪與上述消化液混合,放入細胞培養箱震盪(100 rpm,1小時)。第三次離心(1500 rpm,10分鐘)。使用70 m細胞篩(購於Falcon,BD Bioscience)過濾細胞液,第四次離心(1500 rpm,5 mins)。將上面的油層吸走,後加入培養液,放入75T-flask培養皿(購於Falcon,BD Bioscience)。隔天細胞貼附培養材料,將上清液抽出,加入新的培養液。培養至脂肪細胞8分滿後以0.25%胰蛋白酶/乙二胺四乙酸(購於Gibco)繼代細胞,細胞密度為50000 cells/T-flask。The fat was mixed with the above digestive juice and placed in a cell culture incubator (100 rpm, 1 hour). The third centrifugation (1500 rpm, 10 minutes). The cell broth was filtered using a 70 m cell sieve (purchased from Falcon, BD Bioscience) for a fourth centrifugation (1500 rpm, 5 mins). The above oil layer was aspirated, and then the culture solution was added and placed in a 75T-flask dish (purchased from Falcon, BD Bioscience). The culture material was attached to the cells every other day, the supernatant was withdrawn, and a new culture solution was added. After the cells were cultured to 8 minutes, the cells were subcultured with 0.25% trypsin/ethylenediaminetetraacetic acid (purchased from Gibco) at a cell density of 50000 cells/T-flask.

2.3 神經幹細胞/神經前驅細胞於褐藻酸鹽薄膜之形態分析與分化為神經細胞的情形2.3 Morphological analysis and differentiation of neural stem cells/neural precursor cells into alginate films

鼠腦神經幹細胞/神經前驅細胞萃取步驟如實施例1所述。取得之細胞培養於2D褐藻酸鹽膜上,NSPCs植入含有核藻膠的24孔培養板中(2ml培養液中植入2.5×104 個細胞)。每隔一天更換一半的培養液。The rat brain neural stem cell/neural precursor cell extraction step was as described in Example 1. The obtained cells were cultured on a 2D alginate membrane, and the NSPCs were implanted in a 24-well culture plate containing cyanobacterial gel (2.5 × 10 4 cells were implanted in 2 ml of the culture solution). Replace half of the culture medium every other day.

12-24小時後發現NSPCs在褐藻酸鹽膜上聚集,三天後,發現褐藻酸鹽膜上的細胞團無一致的大小(第七圖)。After 12-24 hours, NSPCs were found to accumulate on the alginate membrane. After three days, the cell clusters on the alginate membrane were found to have no uniform size (Fig. 7).

在分化的表現上,NSPCs培養於2D褐藻酸鹽膜上形成球體時,能表現出神經細胞與神經膠細胞的基因;而培養於TCPS上,呈現類纖維形態的NSPCs卻無法表現神經細胞與神經膠細胞的基因(見第八圖)。In the performance of differentiation, NSPCs can express the genes of nerve cells and glial cells when they are formed on 2D alginate membranes. However, NSPCs which are cultured on TCPS and exhibit fiber-like morphology cannot express nerve cells and nerves. Glue cell genes (see Figure 8).

脂肪幹細胞、神經幹細胞培養28天在A#1及A#2上成球的大小如表所示(培養14天時已有球體形成,且球體大小與28天時相似):The size of the astrocytes and neural stem cells cultured on A#1 and A#2 for 28 days is shown in the table (the spheres are formed when cultured for 14 days, and the sphere size is similar to that at 28 days):

實施例3Example 3

以二種分子量幾丁聚醣薄膜以及纖維素結合功能區域-RGD貼附序列(CBD-RGD)改質之幾丁聚醣薄膜培養脂肪幹細胞Culture of adipose-derived stem cells with chitosan film modified with two molecular weight chitosan films and cellulose-binding functional region-RGD attachment sequence (CBD-RGD)

3.1 二種分子量的幾丁聚醣薄膜製備3.1 Preparation of two molecular weight chitosan films

本實施例係使用分子量不同於前述實施例的幾丁聚醣-3(購於Kiotec),分子量約為170 kDa,及幾丁聚醣-1(購於Fluka),分子量約為510 kDa。秤取0.5g幾丁聚醣粉末溶入於49.5ml二次水,室溫下攪拌半小時後加入0.5ml乙酸繼續攪拌一天。隔天使用濾網過濾雜質即為1%幾丁聚醣溶液。This example uses chitosan-3 (purchased from Kiotec) having a molecular weight different from that of the foregoing examples, having a molecular weight of about 170 kDa, and chitosan-1 (purchased from Fluka) having a molecular weight of about 510 kDa. 0.5 g of chitosan powder was weighed and dissolved in 49.5 ml of secondary water, and stirred at room temperature for half an hour, and then 0.5 ml of acetic acid was added to continue stirring for one day. The filter was used to filter impurities on the next day, which was a 1% chitosan solution.

表3 二種幾丁聚醣的去乙醯度與分子量Table 3 Deacetylation and molecular weight of two chitosan

取1%幾丁聚醣溶液200μl均勻滴入1.5cm圓形玻片,在常溫下自然烘乾1-2天;確定膜乾之後,加入0.5N NaOH蓋過玻片5分鐘,之後用二次水清洗3次後,繼續泡在二次水至隔天;隔天把二次水倒掉,在室溫下自然陰乾存留的二次水後,即為幾丁聚醣-3及幾丁聚醣-1薄膜。另外並以未加生長因子的聚苯乙烯組織培養板(tissue culture polystyrene surface,TCPS)作為控制組之一。Take 200 μl of 1% chitosan solution and evenly drop into a 1.5 cm round slide and dry it naturally for 1-2 days at room temperature. After confirming the film dry, cover the slide with 0.5N NaOH for 5 minutes, then use twice. After washing the water for 3 times, continue to soak in the secondary water to the next day; the next time the second water is poured off, and the secondary water remaining naturally at room temperature remains chitosan-3 and chitosan. Sugar-1 film. In addition, a tissue culture polystyrene surface (TCPS) without growth factor was used as one of the control groups.

另一對照組為聚乙烯醇(PVA)薄膜,因有文獻表示牙胚細胞在PVA膜上,細胞會聚集可行成細胞球幫助硬骨分化;其製備則是秤取2.5g聚乙烯醇(Poly vinyl alcohol,PVA,購於Sigma,Hot water soluble)粉末溶於50ml二次水,利用高溫高壓滅菌釜使之溶解後,溫度降至常溫即為5%聚乙烯醇溶液。取5%聚乙烯醇溶液150μl均勻滴入1.5 cm圓形玻片,放置60℃烘箱下一天即為聚乙烯醇膜。The other control group is a polyvinyl alcohol (PVA) film. Because the literature indicates that the tooth germ cells are on the PVA membrane, the cells can aggregate into cell spheres to help the hard bone differentiation; the preparation is to weigh 2.5 g of polyvinyl alcohol (Poly vinyl). Alcohol, PVA, purchased from Sigma, Hot water soluble) The powder was dissolved in 50 ml of secondary water and dissolved in a high-temperature autoclave. The temperature was lowered to normal temperature to be 5% polyvinyl alcohol solution. 150 μl of a 5% polyvinyl alcohol solution was evenly dropped into a 1.5 cm circular slide, and placed in a 60 ° C oven for one day to form a polyvinyl alcohol film.

3.2 以纖維素結合功能區域-RGD貼附序列(CBD-RGD)改質之幾丁聚醣-1的薄膜製備3.2 Preparation of Chitosan-1 modified by cellulose-binding functional region-RGD attachment sequence (CBD-RGD)

纖維素結合功能區域-RGD貼附序列(CBD-RGD)為中興大學陳震漢教授所提供,來源為真菌Tricoderma konigii的纖維水解酶cellulobiohydrolase I(CBH I)的基因。CBH I的N端有一段36個胺基酸大小的cellulose binding domain(CBD),利用聚合酵素連鎖反應的方法修改的第五個胺基酸的密碼,由原來的tyrosin改成了tryptophan,藉以提高CBD對纖維素的親和力,同時在CBD基因的3端加入一段PT linker及一段RGD序列基因。RGD是細胞貼壁因子(Fibronectin)中促進細胞貼附的最小功能位,纖維素結合功能區域-RGD貼附序列(CBD-RGD)具有如SEQ ID NO:1胺基酸序列,因CBD-RGD有很高的分子量(25 KDa),只需利用庫倫引力,便形成一種可以促進細胞貼附於纖維素上的雙功能蛋白質。The cellulose-binding functional region-RGD-attached sequence (CBD-RGD) was provided by Professor Chen Zhenhan of Zhongxing University and derived from the gene of the cellulolytic enzyme cellulobiohydrolase I (CBH I) of the fungus Tricoderma konigii. At the N-terminus of CBH I, there is a 36 amino acid-sized cellulose binding domain (CBD). The password of the fifth amino acid modified by the polymerization enzyme chain reaction method was changed from the original tyrosin to tryptophan. The CBD has affinity for cellulose, and a PT linker and a RGD sequence gene are added to the 3th end of the CBD gene. RGD is the smallest functional site in cell adhesion factor (Fibronectin) to promote cell attachment, and the cellulose binding functional region-RGD attachment sequence (CBD-RGD) has the amino acid sequence as SEQ ID NO: 1, due to CBD-RGD It has a very high molecular weight (25 KDa) and uses Coulomb's gravitation to form a bifunctional protein that promotes cell attachment to cellulose.

本發明實施例將幾丁聚醣-1形成的薄膜結合CBD-RGD,將該薄膜泡於75%酒精3小時後,使用磷酸鹽緩衝液清洗兩次,放置半小時等幾丁聚醣-1的薄膜乾;將CBD-RGD(4μg/20μl)均勻滴在幾丁聚醣-1的薄膜上(4μg CBD-RGD/1.77 cm2),等1-2小時CBD-RGD乾後,用磷酸鹽緩衝液清洗一次即為以CBD-RGD改質之幾丁聚醣-1的薄膜。In the embodiment of the present invention, the film formed by chitosan-1 is combined with CBD-RGD, and the film is soaked in 75% alcohol for 3 hours, then washed twice with phosphate buffer solution, and placed for half an hour for chitosan-1. The film was dried; CBD-RGD (4 μg/20 μl) was evenly dropped on the film of chitosan-1 (4 μg CBD-RGD/1.77 cm2), and after 1-2 hours of CBD-RGD drying, buffered with phosphate. The liquid was washed once to form a film of chitosan-1 modified with CBD-RGD.

3.3大鼠脂肪幹細胞(rADASs)之萃取及培養3.3 Extraction and culture of rat adipose stem cells (rADASs)

大鼠脂肪幹細胞(rADASs)之萃取及培養如實施例2。Extraction and culture of rat adipose stem cells (rADASs) was as in Example 2.

3.4 脂肪幹細胞在三種幾丁聚醣薄膜之形態分析與分化為心肌細胞的情形3.4 Morphological analysis and differentiation of adipose-derived stem cells into three chitosan films into myocardial cells

本實施例分為兩部份,第一部分為比較組織培養板(T)、聚乙烯醇(P)、幾丁聚醣3(CS3)和幾丁聚醣1(CS1)。將T,P,CS3和CS1薄膜以75%酒精泡3小時,以磷酸鹽緩衝液潤洗後,放入24孔培養板內;使用0.25%胰蛋白酶(購於Gibco)將大鼠脂肪幹細胞(實驗室用細胞代數為2-6代)打下,收集在培養液內,每孔放入5x104 細胞液後,搖晃培養板,使細胞均勻分散,再放入細胞培養箱內培養。This example is divided into two parts. The first part is a comparative tissue culture plate (T), polyvinyl alcohol (P), chitosan 3 (CS3) and chitosan 1 (CS1). The T, P, CS3 and CS1 films were soaked in 75% alcohol for 3 hours, rinsed with phosphate buffer, and placed in a 24-well culture plate; rat adipose-derived stem cells were obtained using 0.25% trypsin (purchased from Gibco) ( The cell number of the laboratory is 2-6 generations, and the cells are collected in the culture solution. After 5× 10 4 cell solution is placed in each well, the plate is shaken to uniformly disperse the cells, and then cultured in a cell culture incubator.

5-azacytidine(5-aza)是DNA去甲基化的化合物,據研究顯示,藉著5-aza不規則地去甲基化,會誘導細胞成為心肌細胞,故在第四天換成含有10M 5-aza(5-azacytidine,Sigma)的培養液,實驗組別分為有添加5-aza(w 5-aza)與無添加5-aza(w/o 5-aza)的組別,所以w/o 5-aza的組別,依舊添加原本的培養液。第五天,將培養液吸出,再次換成不含5-aza的培養液,繼續培養1星期後(共11天),利用反轉錄聚合酶連鎖反應(Reverse transcriptionpolymerase chain reaction,RT-PCR),比較心肌分化的能力,結果如表5與第九、十圖所示。5-azacytidine (5-aza) is a compound that demethylates DNA. According to research, it is induced that cells become cardiomyocytes by irregular demethylation of 5-aza, so it is replaced with 10M on the fourth day. The culture medium of 5-aza (5-azacytidine, Sigma) was divided into groups with 5-aza (w 5-aza) and 5-aza (w/o 5-aza), so w In the group of /o 5-aza, the original culture solution is still added. On the fifth day, the culture solution was aspirated, replaced with a culture medium containing no 5-aza, and further cultured for 1 week (11 days in total) using reverse transcription polymerase chain reaction (RT-PCR). The ability to differentiate cardiac muscles was compared and the results are shown in Tables 5 and IX and X.

第二部分為比較T、CS1與CS1結合CBD-RGD(CS1R)的心肌分化能力。第二部分與第一部分的實驗條件一致,實驗組改為T,CS1,CS1R,由RT-PCR和免疫螢光染色實驗分析分化心肌能力,結果如表5與第九、十圖所示。The second part is to compare the myocardial differentiation ability of T, CS1 and CS1 combined with CBD-RGD (CS1R). The second part was consistent with the experimental conditions of the first part. The experimental group was changed to T, CS1, CS1R. The ability of differentiated myocardium was analyzed by RT-PCR and immunofluorescence staining. The results are shown in Table 5 and ninth and tenth.

表5脂肪幹細胞(rADASs)在不同材料上形成的細胞球大小Table 5 Cell size of adipose stem cells (rADASs) formed on different materials

T: TCPS;P: PVA;CS3: Chitosanl;CS1: Chitosanl;CS1R: Chitosanl+CBD-RGD.T: TCPS; P: PVA; CS3: Chitosanl; CS1: Chitosanl; CS1R: Chitosanl+CBD-RGD.

-:無添加5-aza;+:添加5-aza;X:無細胞球.-: No added 5-aza; +: Add 5-aza; X: Cell-free ball.

由表5與第九、十圖可發現培養於組織培養板之大鼠脂肪幹細胞皆無法成球,在聚乙烯醇上之大鼠脂肪幹細胞在第三天細胞會聚集最大,但之後不管有無加5-aza,細胞皆會從聚集的細胞球跑出,所以在第11天時細胞呈現形態與培養於組織培養板上雷同。在CS3中,第一天可發現細胞逐漸聚集成細胞球,球大小約35μm;第三天,可發現一顆顆的細胞球,大小比第一天大些,約70μm;但繼續培養,會發現較大顆細胞球會逐漸漂走,在第11天發現CS3(-)比CS3(+)的細胞球較小顆。在CS1中,第一天也可發現細胞逐漸聚集成細胞球,球大小約25μm;第三天,可發現一顆顆的細胞球,大小比第一天大些,約55μm;雖然CS1所形成的球比CS3形成的小要小,但球就不易漂走;CS1(-)和CS1(+)在第11天的細胞球都約55μm。在CS1R中,第一天發現細胞未成球,細胞攤開貼在材料上,與TCPS相似,但有逐漸聚集的趨勢;第三天,可發現一顆顆大的細胞球,最大顆有達到250μm;CS1R上形成的球都很大顆,但卻幾乎不會漂走;在第11天,CS1R所形成細胞球比CS3和CS1大100μm以上。在第11天,會發現CS3、CS1、CS1R細胞所聚集的球,有些細胞會跑出細胞球,未加5-aza的組別比有加5-aza的組別,細胞跑出細胞球的趨勢更盛。From Table 5, ninth and tenth, it can be found that the rat adipose stem cells cultured in the tissue culture plate can not form a ball, and the rat adipose stem cells on the polyvinyl alcohol will aggregate the most on the third day, but then whether or not there is no addition. 5-aza, the cells all ran out of the aggregated cell sphere, so on the 11th day, the morphology of the cells was similar to that of the cultured plate. In CS3, on the first day, cells can be found to gradually aggregate into cell spheres with a sphere size of about 35 μm. On the third day, a single cell sphere can be found, which is larger than the first day, about 70 μm. It was found that the larger cell spheres gradually drifted away, and on the 11th day, CS3(-) was found to be smaller than the CS3(+) cell sphere. In CS1, the cells were gradually aggregated into cell spheres on the first day, and the size of the spheres was about 25 μm. On the third day, a single cell sphere was found, which was larger than the first day, about 55 μm; although CS1 was formed. The ball is smaller than the CS3, but the ball is not easy to float; CS1(-) and CS1(+) are about 55μm on the 11th day. In CS1R, on the first day, the cells were found to be unspheronized, and the cells spread out on the material, similar to TCPS, but there is a tendency to gradually aggregate. On the third day, a large cell sphere can be found, and the largest one can reach 250 μm. The balls formed on CS1R are large, but they hardly drift away; on the 11th day, the cell sphere formed by CS1R is more than 100 μm larger than CS3 and CS1. On the 11th day, the balls gathered by CS3, CS1, CS1R cells will be found, some cells will run out of the cell ball, and the group without 5-aza will run out of the cell ball than the group with 5-aza. The trend is even stronger.

因此,第一部分的實驗結果為CS1薄膜最佳,細胞球越大分化效果越好,但PVA聚集的大球會再跑出去貼回材料上,而CS3留不住大球,而使剩下的細胞球比CS1要小,所以分化效果較CS1差。Therefore, the experimental results of the first part are the best for the CS1 film, and the larger the cell sphere, the better the differentiation effect, but the large ball of PVA will run out and paste back to the material, while CS3 can't keep the big ball, leaving the rest. The cell sphere is smaller than CS1, so the differentiation effect is worse than CS1.

比較第一部分的實驗結果,脂肪幹細胞轉換為心肌細胞在材料PVA、CS3、CS1薄膜的基因表現上,由前期轉錄因子的基因GATA4來看,CS1(+)和CS1(-)比其他組有更好的表現;而後期心肌蛋白的基因α-MHC,CS1(+)有最好的表現。故第二部份的實驗以CBD-RGD改質CS1的CS1R及CS1為主。Comparing the results of the first part, the expression of adipose-derived stem cells into cardiomyocytes in the PVA, CS3, and CS1 films showed that CS1(+) and CS1(-) were more common than other groups. Good performance; while the late myocardial protein genes α-MHC, CS1 (+) have the best performance. Therefore, the second part of the experiment is based on CS1R and CS1 of CBD-RGD modified CS1.

第二部分的實驗在第三天細胞會逐漸聚集成球,細胞球大小比CS3和CS1大很多,卻不會像CS3形成的大球容易飄走影響分化。從實驗中看出,CS1R(+)和CS1R(-)在分化到第11天時,球的大小都在155μm左右,但添加5-aza的CS1R(+)分化能力較佳且與從細胞球跑出的細胞寡;以RT-PCR分析驗證,CS1R(+)在GATA4、α-MHC與Troponin I都呈現出比CS1R(-)分化能力較好的趨勢,所以有加5-aza能確實增加分化效果;球的大小與球的形成也決定了心肌分化效果,CS1R>CS1>TCPS。In the second part of the experiment, the cells will gradually aggregate into the ball on the third day. The size of the cell sphere is much larger than that of CS3 and CS1, but it will not be easy to drift away from the large ball formed by CS3. It can be seen from the experiment that CS1R(+) and CS1R(-) have a size of about 155μm when they are differentiated to the 11th day, but the addition of 5-aza to CS1R(+) is better and the cell sphere is The cell oligos ran out; RT-PCR analysis confirmed that CS1R(+) showed a better tendency to differentiate than CS1R(-) in GATA4, α-MHC and Troponin I, so the addition of 5-aza could actually increase Differentiation effect; the size of the ball and the formation of the ball also determine the effect of myocardial differentiation, CS1R>CS1>TCPS.

由免疫染色也可發現,GATA4與α-MHC都只有在細胞球的地方表現,單一顆細胞幾乎無螢光表現,跑出細胞球的細胞也無螢光表現。CBD-RGD改質CS4的基因表現第十一圖可看出前期基因GATA4、後期基因α-MHC Troponin I,分化能力最好為CSR(+),其次為CSR(-),所以添加5-aza對於心肌分化是有幫助的。也由此可看出CBD-RGD改質CS1確實比未改質的CS1有更好的分化能力。因此,脂肪幹細胞在CS1薄膜和CS1R薄膜,在基因表現與免疫化學染色上都有突出的心肌分化效果。It can also be found by immunostaining that both GATA4 and α-MHC are expressed only in the cell sphere, and a single cell has almost no fluorescence, and cells that run out of the cell sphere have no fluorescence. The gene expression of CBD-RGD modified CS4 can be seen in the eleventh figure. The early gene GATA4 and the late gene α-MHC Troponin I have the best differentiation ability of CSR(+), followed by CSR(-), so add 5-aza. It is helpful for myocardial differentiation. It can also be seen from this that CBD-RGD modified CS1 does have better differentiation ability than unmodified CS1. Therefore, adipose-derived stem cells have prominent myocardial differentiation effects in both CS1 and CS1R films in gene expression and immunochemical staining.

另外,CBD-RGD改質之生物高分子包括但不限於幾丁聚醣,本發明提及之生物相容性高分子皆可用CBD-RGD改質以增進成體幹細胞成球狀。In addition, CBD-RGD modified biopolymers include, but are not limited to, chitosan. The biocompatible polymers mentioned in the present invention can be modified with CBD-RGD to promote the formation of adult stem cells into spheres.

實施例4Example 4

以二種幾丁聚醣膜培養牙齦幹細胞及包皮纖維母細胞Cultivating gingival stem cells and foreskin fibroblasts with two chitosan membranes

4.1 幾丁聚醣膜製備4.1 Preparation of chitosan film

利用中黏度的幾丁聚醣-1、去乙醯度77.7%、平均分子量約為510kDa的1%幾丁聚醣(購於Fluka)溶於1%乙酸(購於Showa),過濾後塗佈於15mm蓋玻片(購於Marienfeld)。幾丁聚醣薄膜於室溫風乾,以0.5N氫氧化鈉溶液中和幾丁聚醣的酸性。再以二次蒸餾水清洗幾丁聚醣薄膜上多餘的氫氧化鈉。再將所有的幾丁聚醣膜浸於75%酒精和照射紫外線以達到殺菌效果。該幾丁聚醣膜最後以磷酸鹽緩衝液清洗掉多餘的75%酒精。為比較幾丁聚醣的結果,另以去乙醯度86%、分子量約400kDa的幾丁聚醣膜(購於Sigma)以上述相同方式製備。在本實施例中,以幾丁聚醣-1代表幾丁聚醣(Fluka),以幾丁聚醣-2代表幾丁聚醣(Sigma)。Using a medium viscosity of chitosan-1, a deacetylation degree of 77.7%, an average molecular weight of about 510 kDa of 1% chitosan (purchased from Fluka) dissolved in 1% acetic acid (purchased in Showa), filtered and coated On a 15mm coverslip (purchased from Marienfeld). The chitosan film was air-dried at room temperature, and the acidity of chitosan was neutralized with a 0.5 N sodium hydroxide solution. The excess sodium hydroxide on the chitosan film was washed with double distilled water. Then, all the chitosan membranes were immersed in 75% alcohol and irradiated with ultraviolet rays to achieve a bactericidal effect. The chitosan membrane was finally washed with phosphate buffer to remove excess 75% of the alcohol. To compare the results of chitosan, a chitosan membrane (purchased in Sigma) having a deacetylation degree of 86% and a molecular weight of about 400 kDa was prepared in the same manner as above. In the present example, chitosan-1 represents chitosan (Fluka) and chitosan-2 represents chitosan (Sigma).

4.2 人類牙齦幹細胞及人類包皮纖維母細胞萃取和培養4.2 Extraction and culture of human gingival stem cells and human foreskin fibroblasts

由健康成人牙齦中取得人類牙齦組織。人類牙齦幹細胞培養於含有最低必須α培養液(α-MEM,購於Gibco)加10%胎牛血清和2%抗生素-抗真菌藥物(2 units/ml盤尼西林(基底)、2 μg/ml鏈黴素(基底)和5 ng/ml兩性黴素)(購於Gibco)的細胞培養瓶(Corning)中,培養於37℃,5% CO2 的培養箱中。每兩天更換基本培養液一次。在人類牙齦幹細胞覆蓋達60%到70%時以0.25%胰蛋白酶/乙二胺四乙酸溶液(購於Gibco)收取。本實施例使用第三到七代的牙齦幹細胞。Human gingival tissue is obtained from healthy adult gums. Human gingival stem cells are cultured in a medium containing minimal essential alpha (α-MEM, purchased from Gibco) plus 10% fetal bovine serum and 2% antibiotic-antimycotic (2 units/ml penicillin (basal), 2 μg/ml streptavidin The cells (basin) and 5 ng/ml amphotericin) (purchased from Gibco) were cultured in a cell culture flask (Corning) at 37 ° C in a 5% CO 2 incubator. Replace the basic culture solution once every two days. It was collected as a 0.25% trypsin/ethylenediaminetetraacetic acid solution (purchased from Gibco) when human gingival stem cell coverage reached 60% to 70%. This example uses third to seventh generation gingival stem cells.

經由取得健康成人的包皮纖維母細胞(Human foreskin fibroblasts,HSF)。人類包皮纖維母細胞以含高糖源之DMEM(購於Gibco)添加10%胎牛血清(購於Gibco),200 mM穀氨醯胺(購於Gibco),1% MEM非必需氨基酸100X溶液(購於Sigma),和1%盤尼西林/鏈黴素(5000 units/mL盤尼西林(基底)和5000μg/mL鏈黴素(基底))培養於細胞培養瓶中。HSF培養於37℃,5% CO2 的培養箱中,每兩天更換基本培養液一次。在人類包皮纖維母細胞覆蓋達80%到90%時以0.25%胰蛋白酶/乙二胺四乙酸溶液(購於Gibco)收取。本實施例使用第28代的包皮纖維母細胞(HSF)。By obtaining healthy human adult foreskin fibroblasts (HSF). Human foreskin fibroblasts were supplemented with 10% fetal bovine serum (purchased from Gibco), 200 mM glutamine (purchased from Gibco), 1% MEM non-essential amino acid 100X solution in DMEM containing high sugar source (purchased from Gibco). Purchased in Sigma), and 1% penicillin/streptomycin (5000 units/mL penicillin (basal) and 5000 μg/mL streptomycin (substrate)) were cultured in cell culture flasks. The HSF was cultured in a 37 ° C, 5% CO 2 incubator, and the basic culture solution was changed once every two days. When human foreskin fibroblasts cover 80% to 90%, they are collected in 0.25% trypsin/ethylenediaminetetraacetic acid solution (purchased from Gibco). This example used the 28th generation of foreskin fibroblasts (HSF).

4.3 人類牙齦幹細胞於幾丁聚醣薄膜上之形態分析與分化為軟骨細胞的情形4.3 Morphological analysis and differentiation of human gingival stem cells on chitosan film into chondrocytes

人類牙齦幹細胞(4×104 cells/ml)植入每一置於24孔組織培養板中之幾丁聚醣膜,每兩天更換培養液一次。Human gingival stem cells (4 x 10 4 cells/ml) were implanted into each of the chitosan membranes placed in a 24-well tissue culture plate, and the culture medium was changed once every two days.

細胞植入後三天,加入軟骨細胞誘導培養液以誘導二種幾丁聚醣膜和TCPS上人類牙齦幹細胞的軟骨形成。軟骨細胞誘導培養液含有含高糖源之DMEM(購於Gibco)、10ng/ml的TGF-β3(CytoLab/PeproTech,購於Rehovot,Israel)、10-7 M的dexamethasome(購於Sigma)、50μg/ml的1-抗壞血酸-2-磷酸(購於Sigma),40μg/ml的L-脯氨酸(購於Sigma)、10μg/ml的ITS-預混料10×(購於Sigma)、10%的胎牛血清(購於Gibco),和2%的抗生素-抗真菌劑。人類牙齦幹細胞培養於含誘導培養液之培養箱中7天和14天,每兩天更換誘導培養液一次。人類牙齦幹細胞培養於幾丁聚醣-1、幾丁聚醣-2和TCPS薄膜上植入後三天的形態見第十二圖。Three days after cell implantation, chondrocyte-inducing medium was added to induce cartilage formation of human gingival stem cells on both chitosan membranes and TCPS. The chondrocyte-inducing medium contained DMEM containing high sugar source (purchased from Gibco), 10 ng/ml of TGF-β3 (CytoLab/PeproTech, purchased from Rehovot, Israel), 10 -7 M of dexamethasome (purchased from Sigma), 50 μg /ml of 1-ascorbic acid-2-phosphate (purchased from Sigma), 40 μg/ml of L-valine (purchased from Sigma), 10 μg/ml of ITS-premix 10× (purchased from Sigma), 10% Fetal bovine serum (purchased from Gibco), and 2% antibiotic-antimycotic. The human gingival stem cells were cultured in an incubator containing the inducing culture solution for 7 days and 14 days, and the inducing culture solution was changed once every two days. The morphology of human gingival stem cells cultured on chitosan-1, chitosan-2 and TCPS films for three days after implantation is shown in Fig. 12.

4.4 人類包皮纖維母細胞於幾丁聚醣薄膜上之形態分析與分化為軟骨細胞的情形4.4 Morphological analysis and differentiation of human foreskin fibroblasts on chitosan membranes into chondrocytes

另以相同條件之人類包皮纖維母細胞做為對照組,人類包皮纖維母細胞(4×104 cells/ml)植入每一置於24孔組織培養板中之幾丁聚醣薄膜和TCPS,繼續以基本生長培養液和軟骨細胞誘導培養液培養,每兩天更換培養液一次,人類包皮纖維母細胞培養於幾丁聚醣-1薄膜上植入後三天的形態見第十二圖。In the same condition, human foreskin fibroblasts were used as a control group, and human foreskin fibroblasts (4×10 4 cells/ml) were implanted into each of the chitosan membranes and TCPS placed in a 24-well tissue culture plate. The culture medium was continuously cultured with the basic growth medium and chondrocytes, and the culture solution was changed once every two days. The morphology of the human foreskin fibroblast cultured on the chitosan-1 film for three days after implantation was shown in Fig. 12.

請參閱第十二圖,培養於幾丁聚醣-1薄膜上之人類包皮纖維母細胞無球體形成(第十二圖A)。而培養於幾丁聚醣-1薄膜上之人類牙齦幹細胞有球體形成(第十二圖B),此清楚顯示並非所有的細胞培養於幾丁聚醣-1薄膜上皆會形成球體,因為在本實施例中,本身並不會形成球體的人類牙齦幹細胞卻可於幾丁聚醣-1薄膜上形成球體,而人類包皮纖維母細胞並未形成。第十二圖D即顯示人類牙齦幹細胞培養於TCPS上無球體形成的情況。此外,人類牙齦幹細胞培養於不同分子量的幾丁聚醣薄膜時,形成球的比例也不相同;在第十二圖(B、C),在人類牙齦幹細胞植入後三天,培養於幾丁聚醣-1薄膜形成之球體比在幾丁聚醣-2薄膜上來得多。這表示幾丁聚醣-1可能較幾丁聚醣-2容易誘導人類牙齦幹細胞球體的形成。Referring to Fig. 12, human foreskin fibroblasts cultured on chitosan-1 film have no spheroid formation (Fig. 12A). However, human gingival stem cells cultured on chitosan-1 film have spheroid formation (Fig. 12B), which clearly shows that not all cells cultured on chitosan-1 film will form spheres because In this embodiment, human gingival stem cells which do not form spheres themselves can form spheres on the chitosan-1 film, and human foreskin fibroblasts are not formed. Fig. 12 shows the case where human gingival stem cells are cultured on TCPS without spheroid formation. In addition, when human gingival stem cells are cultured in chitosan films of different molecular weights, the proportion of formed spheres is also different; in the twelfth image (B, C), three days after the implantation of human gingival stem cells, the cells are cultured in several The glycan-1 film formed a much larger sphere than on the chitosan-2 film. This indicates that chitosan-1 may easily induce the formation of human gingival stem cell spheres compared to chitosan-2.

並可進一步參閱第十三圖,係顯示人類牙齦幹細胞培養於幾丁聚醣-1上在植入後12、14、16、18、20、22和24小時同一範圍的活細胞造影。培養於幾丁聚醣-1上之人類牙齦幹細胞於植入後12小時開始形成球體,24小時後初步形成球體。剛植入時人類牙齦幹細胞貼附於幾丁聚醣-1上呈現類纖維的形態。但隨著培養時間的增加,越來越多的人類牙齦幹細胞聚集成球,而貼附於幾丁聚醣-1的人類牙齦幹細胞越來越少。Further reference to Fig. 13 shows the live angiography of human gingival stem cells cultured on chitosan-1 in the same range at 12, 14, 16, 18, 20, 22 and 24 hours after implantation. Human gingival stem cells cultured on chitosan-1 began to form spheres 12 hours after implantation, and initially formed spheres after 24 hours. Human gingival stem cells adhered to chitosan-1 to exhibit a fiber-like morphology just after implantation. However, as the culture time increases, more and more human gingival stem cells gather into the ball, and human gingival stem cells attached to chitosan-1 are less and less.

另外,參閱第十四圖顯示培養於幾丁聚醣和TCPS,有無軟骨誘導培養液在植入後0到3天、加入軟骨誘導培養液後0、1、2、7和14天之人類牙齦幹細胞形態。人類牙齦幹細胞在整個培養過程中為類纖維的形態。隨著細胞培養時間增長,人類牙齦幹細胞形成相對越來越大的細胞球體。此外,許多人類牙齦幹細胞看似自細胞球中遷出,形成細胞團和細胞群。當在添加基本生長培養液之幾丁聚醣-1薄膜上之人類牙齦幹細胞細胞球數量隨時間漸增,大約在軟骨誘導後14天(或植入後17天)看起來似乎有自球體的分泌物。另一方面,培養於TCPS之人類牙齦幹細胞則完全沒有形成球狀。In addition, referring to Fig. 14 shows human gingiva cultured in chitosan and TCPS, with or without cartilage-inducing culture solution at 0 to 3 days after implantation, and 0, 1, 2, 7 and 14 days after the addition of the cartilage-inducing culture solution. Stem cell morphology. Human gingival stem cells are fiber-like throughout the culture process. As cell culture time increases, human gingival stem cells form relatively larger cell spheres. In addition, many human gingival stem cells appear to migrate out of the cell sphere, forming cell clusters and cell populations. When the number of human gingival stem cell spheres on the chitosan-1 film added with the basic growth medium increases with time, it seems to be self-spherical about 14 days after cartilage induction (or 17 days after implantation). Secretion. On the other hand, human gingival stem cells cultured in TCPS did not form a sphere at all.

由前述結果可知,不是所有培養於幾丁聚醣的細胞都會形成球體,例如人類包皮纖維母細胞,也不是所有類型的幾丁聚醣(例如幾丁聚醣-1和幾丁聚醣-2)都有相同誘導細胞成球的效果。培養於幾丁聚醣薄膜上之人類牙齦幹細胞比培養於TCPS之人類牙齦幹細胞有較高的軟骨分化潛能。特別重要的是,培養於無軟骨誘導之幾丁聚醣薄膜的人類牙齦幹細胞之軟骨細胞分化潛能竟能比培養於有軟骨誘導之TCPS上人類牙齦幹細胞要高。換句話說,人類牙齦幹細胞之軟骨細胞分化潛能可因單純培養於本發明幾丁聚醣薄膜上而提升。From the foregoing results, it is known that not all cells cultured in chitosan form spheres, such as human foreskin fibroblasts, nor all types of chitosan (eg, chitosan-1 and chitosan-2). ) have the same effect of inducing cells into a ball. Human gingival stem cells cultured on chitosan membranes have higher cartilage differentiation potential than human gingival stem cells cultured in TCPS. It is particularly important that the chondrocyte differentiation potential of human gingival stem cells cultured in a cartilage-inducible chitosan film is higher than that of human gingival stem cells cultured on a cartilage-induced TCPS. In other words, the chondrocyte differentiation potential of human gingival stem cells can be enhanced by simply culturing on the chitosan film of the present invention.

在確定本發明人類牙齦幹細胞球具有多潛能性和幹性,係藉由NANOG和Oct 4兩種幹性標記決定未分化幹細胞的自我更新過程,因此,NANOG和Oct 4常被用來作為區別未分化細胞的標記,Oct 4特別用來防止細胞分化。另外,神經脊細胞為一短暫多能和遷移能力的細胞群。特定兩段神經脊SLUG和Sox10決定神經脊的規範及分化。本實施例中,我們發現SLUG、Sox 10、NANOG和Oct 4基因表現在培養於幾丁聚醣薄膜之人類牙齦幹細胞皆比培養於TCPS之人類牙齦幹細胞高。這表示只形成於幾丁聚醣上之人類牙齦幹細胞的球體與一般類纖維形態相比,有較高的神經脊基因表現和幹性基因表現。換句話說,形成球體的人類牙齦幹細胞與短暫多能、遷移能力且大多數皆為未分化的細胞相關。另外,在人類牙齦幹細胞球體時似乎在多能、遷移能力和幹性上有增加。這可在植入後0到3天人類牙齦幹細胞在幾丁聚醣薄膜上之球體在SLUG、Sox 10、NANOG和Oct 4基因表現上得到證實。因此,球體的形成幫助維持人類牙齦幹細胞的多潛能性、遷移能力以及幹性。另外,從活細胞成像中觀察上述人類牙齦幹細胞在幾丁聚醣上成球形,球形由人類牙齦幹細胞的連續細胞-基質交互作用和細胞-細胞交互作用導致動態運動而形成。這球體的動態狀態亦證實從神經脊基因表現指出球體中人類牙齦幹細胞的遷移能力。本研究中觀察到人類牙齦幹細胞形成的所有形態中,形成球體內的人類牙齦幹細胞持續進出球體。當人類牙齦幹細胞自球體內遷出,人類牙齦幹細胞會散出並以類纖維形態附著於幾丁聚醣上。因此,球體形態的人類牙齦幹細胞仍維持多潛能性和幹性,這是在類纖維形態的人類牙齦幹細胞所沒有的。In determining the pluripotency and dryness of the human gingival stem cell sphere of the present invention, the self-renewal process of undifferentiated stem cells is determined by two dry markers, NANOG and Oct 4, and therefore, NANOG and Oct 4 are often used as differences. Markers of differentiated cells, Oct 4 is especially used to prevent cell differentiation. In addition, neural ridge cells are a group of transient pluripotent and migratory cells. Specific two-segment neural ridges SLUG and Sox10 determine the specification and differentiation of the neural ridge. In this example, we found that the SLUG, Sox 10, NANOG, and Oct 4 genes exhibited higher levels of human gingival stem cells cultured in chitosan films than human gingival stem cells cultured in TCPS. This indicates that the spheres of human gingival stem cells formed only on chitosan have higher neurological gene expression and dry gene expression than general fiber morphology. In other words, human gingival stem cells that form spheres are associated with transient pluripotent, migratory, and mostly undifferentiated cells. In addition, there appears to be an increase in pluripotency, migration capacity and dryness in human gingival stem cell spheres. This was confirmed by the spheroids of human gingival stem cells on the chitosan film on the SLUG, Sox 10, NANOG and Oct 4 gene expressions 0 to 3 days after implantation. Thus, the formation of spheres helps maintain the pluripotency, migration and dryness of human gingival stem cells. In addition, it was observed from live cell imaging that the above human gingival stem cells were spherical on chitosan, and the spherical shape was formed by continuous cell-matrix interaction and cell-cell interaction of human gingival stem cells resulting in dynamic movement. The dynamic state of the sphere also confirms the ability of the human gingival stem cells to migrate from the neural ridge gene. In this study, it was observed that in all forms of human gingival stem cell formation, human gingival stem cells forming spheroids continued to enter and exit the sphere. When human gingival stem cells migrate out of the spheroid, human gingival stem cells will emanate and attach to chitosan in a fibrillar form. Therefore, the globular morphology of human gingival stem cells still maintains pluripotency and dryness, which is not found in humanoid gingival stem cells in the fibrillar form.

另外,將骨髓間葉幹細胞(bone marrow-derived MSCs)培養於幾丁聚醣-1膜上,亦會形成球形(見第十五圖)。In addition, bone marrow-derived MSCs are cultured on the chitosan-1 membrane and also form a sphere (see Figure 15).

實施例5Example 5

以幾丁聚醣和幾丁聚醣-透明質酸膜培養胎盤、脂肪幹細胞Placental and adipose-derived stem cells cultured with chitosan and chitosan-hyaluronic acid membrane

5.1 幾丁聚醣和幾丁聚醣-透明質酸(HA)薄膜製備5.1 Preparation of chitosan and chitosan-hyaluronic acid (HA) film

幾丁聚醣-1粉末分子量為510kDa(購於Fluka)溶於1%乙酸以取得1%幾丁聚醣溶液。溶液(300μl)塗佈於24孔培養板的每一孔中。樣本置於層流櫃24小時候溶劑蒸發後,即為幾丁聚醣膜。每孔加入氫氧化鈉(0.5N)停留30分鐘,再以磷酸鹽緩衝液清洗數次。The chitosan-1 powder has a molecular weight of 510 kDa (purchased from Fluka) dissolved in 1% acetic acid to obtain a 1% chitosan solution. The solution (300 μl) was applied to each well of a 24-well culture plate. When the sample is placed in the laminar flow chamber 24, the solvent evaporates, which is a chitosan film. Sodium hydroxide (0.5 N) was added to each well for 30 minutes, and then washed several times with phosphate buffer.

製備幾丁聚醣-透明質酸膜,透明質酸溶液(購於科研或資生堂皆有,效果皆相同)300μl以0.1、0.5或2.5mg/cm2 之不同的量加入幾丁聚醣膜中。透明質酸帶有很強的負電,會立刻與帶正電的幾丁聚醣膜結合。幾丁聚醣和不同透明質酸劑量的幾丁聚醣-透明質酸膜以C、CH0.1、CH0.5和CH2.5來簡稱。不同透明質酸量的幾丁聚醣-透明質酸膜以磷酸鹽緩衝液清洗5次以去除未鍵結的透明質酸然後凍乾。CH0.1、CH0.5和CH2.5的有效吸收率分別為94%、95%和89%。透明質酸被吸收的總量依初始添加透明質酸量增加而增加。另外並以未加生長因子的聚苯乙烯組織培養板(tissue culture polystyrene surface,TCPS)作為對照組。Preparation of chitosan-hyaluronic acid film, hyaluronic acid solution (purchased in scientific research or Shiseido, the effect is the same) 300μl added to the chitosan film in different amounts of 0.1, 0.5 or 2.5mg/cm 2 . Hyaluronic acid has a strong negative charge and will immediately bind to the positively charged chitosan membrane. Chitosan and different hyaluronic acid doses of chitosan-hyaluronic acid membrane are abbreviated as C, CH0.1, CH0.5 and CH2.5. The chitosan-hyaluronic acid membranes of different amounts of hyaluronic acid were washed 5 times with phosphate buffer to remove unbound hyaluronic acid and then lyophilized. The effective absorption rates of CH0.1, CH0.5 and CH2.5 were 94%, 95% and 89%, respectively. The total amount of hyaluronic acid absorbed increases as the amount of hyaluronic acid initially added increases. In addition, a tissue culture polystyrene surface (TCPS) without growth factor was used as a control group.

5.2 人類胎盤幹細胞(hPDMSC)之萃取和培養5.2 Extraction and culture of human placental stem cells (hPDMSC)

取健康母體懷孕後期(38-40周)捐贈之胎盤。將胎盤以磷酸鹽緩衝液清洗幾次然後將之打碎和在37℃以0.25%胰蛋白酶酵素處理約10分鐘。在打碎和酵素處理後,此勻漿培養於DMEM-LG(Dulbecco's Modified Eagle Medium-low glucose)(購於Gibco)完全培養基,添加10%胎牛血清(購於Gibco)、10 mg/l盤尼西林-鏈黴素和10 mg/l L-穀胺醯胺(購於Tedia)。細胞培養於37℃水氣飽和的空氣,以及5%的CO2 。每週更換培養液兩次。The placenta donated by the healthy mother during the late pregnancy (38-40 weeks). The placenta was washed several times with phosphate buffer and then disrupted and treated with 0.25% trypsin at 37 °C for about 10 minutes. After shredding and enzyme treatment, the homogenate was cultured in DMEM-LG (Dulbecco's Modified Eagle Medium-low glucose) (purchased in Gibco) complete medium, 10% fetal bovine serum (purchased in Gibco), 10 mg/l penicillin - Streptomycin and 10 mg/l L-glutamine (purchased from Tedia). The cells were cultured at 37 ° C with water-saturated air and 5% CO 2 . The culture medium was changed twice a week.

5.3 脂肪幹細胞(hADAS)之萃取和培養5.3 Extraction and culture of adipose stem cells (hADAS)

脂肪幹細胞可於脂肪組織中取得。從脂肪組織中以酶萃取出細胞。先將脂肪組織打碎成數塊再以200 U/ml第一型膠原酶(購於Sigma-Aldrich)磷酸鹽緩衝液中在37℃輕拌30分鐘。將勻漿培養於DMEM-LG(Dulbecco's Modified Eagle Medium-low glucose)(購於Gibco)完全培養基中,添加10%(v/v)胎牛血清(購於Gibco)、10 mg/l盤尼西林-鏈黴素。培養箱維持37℃/5% CO2 。每週更換培養液兩次。Adipose stem cells can be obtained in adipose tissue. The cells are extracted by enzymatic extraction from adipose tissue. The adipose tissue was first broken into several pieces and then gently mixed in a phosphate buffer of type I collagenase (purchased in Sigma-Aldrich) at 200 U/ml for 30 minutes at 37 °C. The homogenate was cultured in DMEM-LG (Dulbecco's Modified Eagle Medium-low glucose) (purchased in Gibco) complete medium, and 10% (v/v) fetal bovine serum (purchased from Gibco), 10 mg/l penicillin-chain was added. Mycin. The incubator maintained 37 ° C / 5% CO 2 . The culture medium was changed twice a week.

5.4 胎盤幹細胞和脂肪幹細胞於幾丁聚醣和幾丁聚醣-透明質酸薄膜上的形態分析及分化為軟骨細胞的情形5.4 Morphological analysis and differentiation of placental stem cells and adipose stem cells on chitosan and chitosan-hyaluronic acid films into chondrocytes

脂肪幹細胞和胎盤幹細胞(3×104 個細胞)植入每一含基本培養液之幾丁聚醣膜培養三天後,將培養液更換為軟骨細胞誘導培養液。誘導培養液為DMEM-LG,含有10 ng/ml TGF-β3(購於CytoLab/Peprotech,Rehovot,Israel)、0.1 μM dexamethasome、50 μg/ml L-ascobate-2-磷酸,40 μg/ml L-脯氨酸(Sigma)、1%胰島素-轉鐵因子-硒補充劑(ITS+premix)100×(購於Sigma)以及1%盤尼西林-鏈黴素。誘導培養液每週更換兩次。另一組(植入後3天)仍以基本培養液培養作為控制組。Adipose stem cells and placental stem cells (3 × 10 4 cells) were cultured for three days after each of the chitosan membranes containing the basic culture medium, and the culture solution was changed to a chondrocyte-inducing culture solution. The induction medium was DMEM-LG containing 10 ng/ml TGF-β3 (purchased from CytoLab/Peprotech, Rehovot, Israel), 0.1 μM dexamethasome, 50 μg/ml L-ascobate-2-phosphate, 40 μg/ml L- Proline (Sigma), 1% insulin-transferrin-selenium supplement (ITS+premix) 100× (purchased in Sigma) and 1% penicillin-streptomycin. The induction medium was changed twice a week. The other group (3 days after implantation) was still cultured in the basic culture medium as a control group.

脂肪幹細胞在培養於幾丁聚醣-透明質酸薄膜上1天後,脂肪幹細胞聚集而成的三維球形成。隨著幾丁聚醣膜上的透明質酸增加,形成的球體越明顯,且數量和大小皆較大。脂肪幹細胞和胎盤幹細胞培養於TCPS、幾丁聚醣、幾丁聚醣-透明質酸膜上第3天的形態如第十六圖所示。培養於薄膜上3天後,培養於幾丁聚醣和幾丁聚醣-透明質酸薄膜之脂肪幹細胞和胎盤幹細胞皆形成球狀。不同細胞在這些膜上平均細胞球的大小列於表6。One day after the adipose stem cells were cultured on the chitosan-hyaluronic acid film, a three-dimensional sphere formed by aggregation of the adipose stem cells was formed. As the hyaluronic acid on the chitosan film increases, the spheres formed are more pronounced and larger in number and size. The morphology of adipose stem cells and placental stem cells cultured on TCPS, chitosan, chitosan-hyaluronic acid membrane on day 3 is as shown in Fig. 16. After 3 days of culture on the film, the adipose stem cells and placental stem cells cultured in the chitosan and chitosan-hyaluronic acid films were spherical. The average cell size of the different cells on these membranes is listed in Table 6.

表6胎盤幹細胞與脂肪幹細胞在不同膜上形成之球體平均大小Table 6 Average size of spheres formed by different types of placental stem cells and adipose stem cells on different membranes

*每一平均值為至少20個球體直徑之平均*Each average is the average of at least 20 sphere diameters

在確定本發明在培養期間脂肪幹細胞和胎盤幹細胞的幹性標記基因(Oct4、Sox2和Nanog)的表現。在基本培養液的脂肪幹細胞和胎盤幹細胞之Oct4、Sox2和Nanog的mRNA表現以即時RT-PCR分析。在第十七圖顯示脂肪幹細胞培養於不同材料和TCPS對照的Oct4、Sox2和Nanog之mRNA表現量化結果。在幾丁聚醣和幾丁聚醣-透明質酸之Oct4、Sox2和Nanog基因表現在第3天增加,然後在第7和第10天降低。在第一天和第三天,這些基因的表現在CH2.5薄膜上為最高(p<0.05)。The expression of the dry marker genes (Oct4, Sox2 and Nanog) of the adipose stem cells and placental stem cells of the present invention during the culture was determined. mRNA expression of Oct4, Sox2 and Nanog in adipose stem cells and placental stem cells in basic culture was analyzed by real-time RT-PCR. Figure 17 shows the quantitative results of mRNA expression of Oct4, Sox2 and Nanog in adipose stem cells cultured in different materials and TCPS controls. The Oct4, Sox2, and Nanog genes in chitosan and chitosan-hyaluronic acid increased on day 3 and then decreased on days 7 and 10. On the first and third days, the performance of these genes was highest on the CH2.5 film (p < 0.05).

大致上,胎盤幹細胞的這些基因可被幾丁聚醣和幾丁聚醣-透明質酸膜上的向上調節可維持七天的時間。在脂肪幹細胞中,這些基因的向上調節可維持三天的時間。在脂肪幹細胞中,CH2.5比其他材料維持這些基因效果較好。在胎盤幹細胞中,CH 0.5與CH 2.5維持這些基因特性表現的效果一樣好。In general, these genes for placental stem cells can be up-regulated on chitosan and chitosan-hyaluronic acid membranes for up to seven days. In adipose stem cells, upregulation of these genes can be maintained for three days. In adipose stem cells, CH2.5 maintains these genes better than other materials. In placental stem cells, CH 0.5 and CH 2.5 are equally effective at maintaining the characteristics of these genes.

脂肪幹細胞和胎盤幹細胞培養於幾丁聚醣和幾丁聚醣-透明質酸(與TCPS)在軟骨誘導後7天,以RT-PCR量化脂肪幹細胞和胎盤幹細胞的軟骨細胞基因表現,結果如第十八圖。在形成球體後,軟骨基因表現(Sox-9、aggrecan和collagen type Ⅱ)在軟骨誘導下顯著增加(第十八圖B、D、F),與培養於基本培養液比較(第十八圖A、C、E)。當脂肪幹細胞培養於有基本培養液之幾丁聚醣和幾丁聚醣-透明質酸時,這些基因有高度的表現(與TCPS/基本培養液比較)。另一方面,當胎盤幹細胞培養於有基本培養液之幾丁聚醣和幾丁聚醣-透明質酸上時,這些基因呈低度表現(與TCPS/基本培養液比較)。培養於有基本培養液的幾丁聚醣和幾丁聚醣-透明質酸之脂肪幹細胞的軟骨分化能力比胎盤幹細胞要好,特別是幾丁聚醣-透明質酸。由上述結果顯示,胎盤幹細胞和脂肪幹細胞在有軟骨誘導液的情況下,培養於幾丁聚醣-透明質酸之軟骨基因表現為最高,其次為幾丁聚醣,最低為TCPS。因此,有吸收透明質酸之幾丁聚醣膜,可大幅增進胎盤幹細胞和脂肪幹細胞聚集形成一球體細胞群體,且維持胎盤幹細胞和脂肪幹細胞自我更新和幹性,以及往後增進軟骨的分化能力。Adipose-derived stem cells and placental stem cells were cultured in chitosan and chitosan-hyaluronic acid (with TCPS). After 7 days of cartilage induction, the chondrocyte gene expression of adipose stem cells and placental stem cells was quantified by RT-PCR. Eighteen pictures. After the formation of spheres, cartilage gene expression (Sox-9, aggrecan and collagen type II) was significantly increased under cartilage induction (Fig. 18, B, D, F), compared with cultured medium (Fig. 18) , C, E). When adipose stem cells are cultured in chitosan and chitosan-hyaluronic acid with a basic culture medium, these genes are highly expressed (compared to TCPS/basic medium). On the other hand, when placental stem cells were cultured on chitosan and chitosan-hyaluronic acid in a basic culture medium, these genes showed low performance (compared with TCPS/basic medium). The adipose stem cells cultured in chitosan and chitosan-hyaluronic acid having a basic culture solution have better cartilage differentiation ability than placental stem cells, particularly chitosan-hyaluronic acid. From the above results, the placental stem cells and adipose stem cells have the highest cartilage gene cultured in chitosan-hyaluronic acid in the presence of cartilage-inducing liquid, followed by chitosan, and the lowest is TCPS. Therefore, a chitosan membrane that absorbs hyaluronic acid can greatly enhance the aggregation of placental stem cells and adipose stem cells to form a spheroid cell population, and maintain the self-renewal and dryness of placental stem cells and adipose stem cells, and enhance the differentiation of cartilage in the future. .

本發明實施例誘導胎盤幹細胞和脂肪幹細胞在薄膜上自發地形成立體球體,在塗佈透明質酸之幾丁聚醣上形成許多大球體,亦證實透明質酸能增進球體形成。In the embodiment of the present invention, the placental stem cells and the adipose stem cells are spontaneously formed on the film to form a stereoscopic sphere, and a plurality of large spheres are formed on the chitosan coated with hyaluronic acid, and it is also confirmed that hyaluronic acid can enhance the formation of the sphere.

實施例6Example 6

以幾丁聚醣-銀耳多醣培養脂肪幹細胞、神經幹細胞Culture of adipose stem cells and neural stem cells with chitosan-white fungus polysaccharide

6.1 幾丁聚醣-銀耳多醣膜製備6.1 Preparation of chitosan-twinkle polysaccharide membrane

利用實施例5之1%的幾丁聚醣-1(購於Fluka)做為基材,以實施例5的幾丁聚醣膜製備方法製備,先加入3mg的幾丁聚醣於24孔培養板的每一孔中,每孔再加入3mg銀耳多醣,比例為1:1。Using 1% of chitosan-1 (purchased from Fluka) of Example 5 as a substrate, and preparing the chitosan film preparation method of Example 5, first adding 3 mg of chitosan to culture in 24 wells. In each well of the plate, 3 mg of Tremella polysaccharide was added to each well in a ratio of 1:1.

6.2 萃取和培養脂肪幹細胞、神經幹細胞6.2 Extraction and culture of adipose stem cells, neural stem cells

脂肪幹細胞的萃取及培養同實施例5。The extraction and culture of adipose stem cells were the same as in Example 5.

神經幹細胞的萃取及培養同實施例2。The extraction and culture of neural stem cells were the same as in Example 2.

6.3 脂肪幹細胞、神經幹細胞培養於幾丁聚醣-銀耳多醣膜上的形態6.3 Morphology of adipose-derived stem cells and neural stem cells cultured on chitosan-twinkle polysaccharide membrane

脂肪幹細胞培養於幾丁聚醣-銀耳多醣膜上24小時和48小時的形態如第十九圖,另外神經幹細胞亦成球形。The morphology of the adipose stem cells cultured on the chitosan-twinkle polysaccharide membrane for 24 hours and 48 hours is as shown in Fig. 19, and the neural stem cells are also spherical.

幾丁聚醣與銀耳多醣之比例包括但不限於1:1,約3:0.4至3:4.5皆可。The ratio of chitosan to tremella polysaccharides includes, but is not limited to, 1:1, and is about 3:0.4 to 3:4.5.

實施例7Example 7

以幾丁聚醣、幾丁聚醣-透明質酸、聚己內酯、聚己內酯-透明質酸膜培養肺幹細胞(lung stem cell,LSC)Lung stem cell (LSC) cultured with chitosan, chitosan-hyaluronic acid, polycaprolactone, polycaprolactone-hyaluronic acid membrane

7.1 幾丁聚醣、幾丁聚醣-透明質酸、聚己內酯(polycaprolactone,PCL)、聚己內酯-透明質酸膜製備7.1 Preparation of chitosan, chitosan-hyaluronic acid, polycaprolactone (PCL), polycaprolactone-hyaluronic acid membrane

幾丁聚醣、幾丁聚醣-透明質酸脂製備與實施例5相同。The preparation of chitosan and chitosan-hyaluronic acid ester was the same as in Example 5.

取分子量80kDa之聚己內酯(購於Sigma),溶於1,4-二氧六環(1,4-dioxane),即為11%之聚己內酯。將上述聚己內酯鑄於玻片,即為聚己內酯薄膜。然後以大氣電漿(能量1 kW,購於德國Plasmatreat)以距離10 mm速度6 m/min掃描後,將300 ul 2.95 mg/ml透明質酸水溶液滴在上面,隔夜後洗去,透明質酸就會電漿接枝於表面,密度為0.5 mg/cm2Polycaprolactone (purchased in Sigma) having a molecular weight of 80 kDa was dissolved in 1,4-dioxane, which was 11% of polycaprolactone. The above polycaprolactone is cast on a glass slide, which is a polycaprolactone film. Then, after scanning at a distance of 10 mm 6 m/min with atmospheric plasma (energy 1 kW, purchased from Plasmatreat, Germany), 300 ul of 2.95 mg/ml aqueous hyaluronic acid solution was dripped on it, and washed away overnight, hyaluronic acid. The plasma is grafted onto the surface at a density of 0.5 mg/cm 2 .

7.2 小鼠肺幹細胞(lung stem cell,LSC)之萃取及培養7.2 Extraction and culture of mouse lung stem cells (LSC)

小鼠肺幹細胞係依據Ling TY,Kuo MD,Li CL,Yu AL,Huang YH,Wu TJ,Lin YC,Chen SH,Yu J. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus(SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9530-5. Epub 2006 Jun 13,由小鼠肺臟所取得。The mouse lung stem cell line is based on Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ, Lin YC, Chen SH, Yu J. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci US A. 2006 Jun 20; 103(25): 9530-5. Epub 2006 Jun 13, obtained from mouse lung.

7.3 肺幹細胞培養於幾丁聚醣、幾丁聚醣-透明質酸、聚己內酯及聚己內酯-透明質酸膜之結果7.3 Results of culture of lung stem cells in chitosan, chitosan-hyaluronic acid, polycaprolactone and polycaprolactone-hyaluronic acid membrane

肺幹細胞在幾丁聚醣以及幾丁聚醣-透明質酸上會形成球狀,且nanog/oct4基因表現提升。Lung stem cells form a globular shape on chitosan and chitosan-hyaluronic acid, and the nanog/oct4 gene is improved.

而在聚己內酯及聚己內酯-透明質酸膜上亦會成球(見第二十圖),聚己內酯表面呈晶狀排列,故看得到圓晶(似表面龜裂);且幹性基因nanog/oct4表現提升(第二十一圖)。On the polycaprolactone and polycaprolactone-hyaluronic acid film, it will also form a sphere (see Figure 20). The surface of polycaprolactone is arranged in a crystal form, so that round crystals (like surface cracks) can be seen. And the performance of the dry gene nanog/oct4 is improved (21st).

因此,該些結果顯示本發明提供之一多能成體幹細胞、其醫藥組合物、以及用於生產該成體幹細胞的方法,係藉由生物相容性高分子接觸,確實能達到細胞自我更新及維持幹性(stemness)的突出效果。Therefore, the results show that the present invention provides a pluripotent adult stem cell, a pharmaceutical composition thereof, and a method for producing the same, which are capable of achieving cell self-renewal by contact with a biocompatible polymer. Maintain the outstanding effect of stemness.

<110> 國立台灣大學<110> National Taiwan University

<120> 使成體幹細胞產生為一球體細胞群體的方法<120> Method for producing adult stem cells as a spheroid cell population

<130> 990544-I1<130> 990544-I1

<160> 1<160> 1

<170> PatentIn version 3.3<170> PatentIn version 3.3

<210> 1<210> 1

<211> 48<211> 48

<212> PRT<212> PRT

<213> 人工合成<213> Synthetic

<220><220>

<223> 纖維素結合功能區域-RGD貼附序列(CBD-RGD)<223> Cellulose Binding Functional Region - RGD Attachment Sequence (CBD-RGD)

<400> 1<400> 1

第一圖係培養於a.明膠和b.組織培養板(TCPS)上三天之神經幹細胞;無任何球體形成。比例尺為100μm。The first panel is a neural stem cell cultured on a. gelatin and b. tissue culture plate (TCPS) for three days; no spheroid formation. The scale bar is 100 μm.

第二圖係為培養於不同幾丁聚醣(a.幾丁聚醣-1 b.幾丁聚醣-2)之神經幹細胞在第1、2、3天之形態;比例尺為100μm。The second figure is the morphology of neural stem cells cultured on different chitosan (a. chitosan-1 b. chitosan-2) on days 1, 2, and 3; the scale bar is 100 μm.

第三圖係為培養於幾丁聚醣-1之神經幹細胞五天後利用掃描式電子顯微鏡(SEM)結果:a.俯視圖b.側視圖。The third panel is the results of scanning electron microscopy (SEM) after five days of culture of chitosan-1 neural stem cells: a. Top view b. Side view.

第四圖係為第a. 3 b. 5 c. 7 d. 15 e. 20 f. 25天細胞形態(左)和F1B-螢光綠蛋白表現(右);比例尺為200μm。The fourth panel is the a. 3 b. 5 c. 7 d. 15 e. 20 f. 25-day cell morphology (left) and F1B-fluorescein expression (right); scale bar is 200 μm.

第五圖係為培養於幾丁聚醣-1之神經幹細胞在a. F1B-螢光綠蛋白和b. nestin(免疫染色)第1、4、21天的表現;比例尺為100μm。The fifth panel shows the performance of neural stem cells cultured in chitosan-1 on days 1, 4, and 21 of a. F1B-fluorescent green protein and b. nestin (immunofection); the scale bar is 100 μm.

第六圖係為培養於幾丁聚醣-1之a. DAPI(細胞核)和b. β3-tubulin(免疫染色)在第4、14、21天之球體形態;比例尺為100μm。The sixth figure is the sphere morphology of a. DAPI (nucleus) and b. β3-tubulin (immuno staining) cultured on chitosan-1 on days 4, 14, and 21; the scale bar is 100 μm.

第七圖係為培養於四種2D褐藻酸鹽膜(a. A#1 b. A#2)之神經幹細胞/神經前驅細胞三天後的型態;比例尺為250μm。The seventh panel is a type of neural stem cells/neural precursor cells cultured in four 2D alginate membranes (a. A#1 b. A#2) three days later; the scale bar is 250 μm.

第八圖係為NSPCs培養於褐藻酸鹽薄膜和TCPS上之分化能力比較;TuJ1為神經細胞、GFAP為神經膠細胞。The eighth figure is the comparison of the differentiation ability of NSPCs cultured on alginate film and TCPS; TuJ1 is a nerve cell and GFAP is a glial cell.

第九圖係為大鼠脂肪幹細胞在TCPS(T)、PVA(P)材料上培養第1天、3天和第11天的細胞球形態;-:無添加5-aza;+:添加5-azaThe ninth graph shows the cell pellet morphology of rat adipose stem cells cultured on TCPS(T) and PVA(P) materials on days 1, 3 and 11; -: no addition of 5-aza; +: addition of 5- Aza

第十圖係為大鼠脂肪幹細胞(rADASs)在Chitosan3(CS3)、Chitosan 1(CS1)、Chitosan1+CBD-RGD(CS1R)材料上培養第1天、3天和第11天的細胞球形態;-:無添加5-aza;+:添加5-azaThe tenth figure shows the cell morphology of rat adipose stem cells (rADASs) cultured on Chitosan3 (CS3), Chitosan 1 (CS1), Chitosan1+CBD-RGD (CS1R) materials on days 1, 3 and 11; -: No added 5-aza; +: Add 5-aza

第十一圖係為大鼠脂肪幹細胞(rADASs)在TCPS(T)、Chitosan 1(CS1)、Chitosan1+CBD-RGD(CS1R)材料上利用RT-PCR實驗後的毛細管電泳圖;Cardiomyocyte positive(CP):無添加5-aza;+:添加5-aza。The eleventh figure is a capillary electropherogram of rat adipose-derived stem cells (rADASs) after RT-PCR on TCPS(T), Chitosan 1 (CS1), Chitosan1+CBD-RGD (CS1R) materials; Cardiomyocyte positive (CP) ): No added 5-aza; +: Add 5-aza.

第十二圖係為人類包皮纖維母細胞培養於A.幾丁聚醣-1,人類牙齦幹細胞培養於B.幾丁聚醣-1 C.幾丁聚醣-2 D. TCPS植入三天後之細胞形態;比例尺為100μm;放大倍率為10倍。The twelfth picture shows human foreskin fibroblasts cultured in A. chitosan-1, human gingival stem cells cultured in B. chitosan-1 C. chitosan-2 D. TCPS implantation for three days After the cell morphology; the scale is 100 μm; the magnification is 10 times.

第十三圖係為人類牙齦幹細胞培養於幾丁聚醣膜上在植入後A. 12 B. 14 C. 16 D. 18 E. 20 F. 22 G. 24小時同一範圍之形態;比例尺為100μm,放大倍率為10倍。The thirteenth figure is the morphology of the human gingival stem cells cultured on the chitosan membrane after implantation. A. 12 B. 14 C. 16 D. 18 E. 20 F. 22 G. 24 hours in the same range; 100 μm, the magnification is 10 times.

第十四圖係為人類牙齦幹細胞培養於幾丁聚醣在植入後第A. 0 B.1 C. 2 D. 3天之形態;和培養於TCPS在植入後第E. 0 F. 1 G. 2 H. 3天之形態;人類牙齦幹細胞培養於I.含誘導培養液之幾丁聚醣J.含基本培養液之幾丁聚醣和K.含誘導培養液之TCPS L.含基本培養液之TCPS 1天後之形態;人類牙齦幹細胞培養於M.含誘導培養液之幾丁聚醣N.含基本培養液之幾丁聚醣和O.含誘導培養液之TCPS P.含基本培養液之TCPS在軟骨誘導後2天之形態;人類牙齦幹細胞培養於Q.含誘導培養液之幾丁聚醣R.含基本培養液之幾丁聚醣和S.含誘導培養液之TCPS T.含基本培養液之TCPS在軟骨誘導後7天之形態;人類牙齦幹細胞培養於U.含誘導培養液之幾丁聚醣V.含基本培養液之幾丁聚醣和W.含誘導培養液之TCPS X.含基本培養液之TCPS在軟骨誘導後14天之形態;比例尺為100μm,放大倍率為10倍。The fourteenth figure is a human gingival stem cell cultured in the form of chitosan after implantation of A. 0 B.1 C. 2 D. 3 days; and cultured in TCPS after implantation E. 0 F. 1 G. 2 H. 3 days of morphology; human gingival stem cells cultured in I. Chitosan containing induced culture solution J. Chitosan containing basic culture solution and K. TCPS containing induction culture solution The morphology of the basic culture solution after 1 day of TCPS; human gingival stem cells cultured in M. chitosan containing induction culture solution N. chitosan containing basic culture solution and O. TCPS containing induction culture solution The morphology of TCPS in the basic culture medium is 2 days after cartilage induction; human gingival stem cells are cultured in Q. Chitosan containing induction culture solution R. Chitosan containing basic culture solution and S. TCPS containing induction culture solution T. The morphology of the TCPS containing the basic culture medium 7 days after the cartilage induction; the human gingival stem cells were cultured in U. The chitosan containing the induced culture solution V. The chitosan containing the basic culture solution and the W. containing induction culture TCPS of liquid X. The form of TCPS containing basic culture solution was 14 days after cartilage induction; the scale was 100 μm, and the magnification was 10 times.

第十五圖係為骨髓間葉幹細胞培養於幾丁聚醣膜上4天後之細胞形態。The fifteenth figure is the cell morphology of the mesenchymal stem cells cultured on the chitosan membrane for 4 days.

第十六圖係為不同幹細胞培養於不同材料上。(A)培養於TCPS之細胞形態(B)培養於含基本培養液之幾丁聚醣和幾丁聚醣-透明質酸三天後之細胞形態。The sixteenth figure is the cultivation of different stem cells on different materials. (A) Cell morphology cultured in TCPS (B) Cell morphology after incubation with chitosan and chitosan-hyaluronic acid containing the basic culture solution for three days.

第十七圖係為脂肪幹細胞培養於含基本培養液幾丁聚醣和幾丁聚醣-透明質酸和TCPS第10天的幹性基因(Oct4、Sox2和Nanog)之mRNA表現量化結果。The seventeenth figure is the quantitative result of mRNA expression of adipose stem cells cultured in the basic culture medium chitosan and chitosan-hyaluronic acid and TCPS dry genes (Oct4, Sox2 and Nanog) on the 10th day.

第十八圖係為培養於幾丁聚醣和幾丁聚醣-透明質酸膜(與TCPS比較)在軟骨誘導後7天以RT-PCR量化脂肪幹細胞和胎盤幹細胞的軟骨細胞基因表現。Figure 18 shows the chondrocyte gene expression of adipose stem cells and placental stem cells quantified by RT-PCR 7 days after cartilage induction in chitosan and chitosan-hyaluronic acid membranes (compared to TCPS).

第十九圖係為培養脂肪幹細胞於幾丁聚醣-銀耳多醣膜在(A) 24小時,及(B) 48小時後之形態。The nineteenth figure is the morphology of the cultured adipose stem cells in the chitosan-twinkle polysaccharide film at (A) 24 hours, and (B) 48 hours later.

第二十圖係為培養肺幹細胞於聚己內酯、聚己內酯-幾丁聚醣膜上第1、2天之形態。The twentieth figure shows the morphology of the cultured lung stem cells on the polycaprolactone and polycaprolactone-chitosan membranes on the first and second days.

第二十一圖係為肺幹細胞培養於聚己內酯、聚己內酯-幾丁聚醣膜上第1、3天幹性基因(actin、Oct4、Sox2和Nanog)之mRNA表現結果。The twenty-first figure shows the mRNA expression results of the stem genes (actin, Oct4, Sox2, and Nanog) on the first and third days of the culture of the lung stem cells in the polycaprolactone and polycaprolactone-chitosan membranes.

Claims (20)

一種使成體幹細胞產生為一球體細胞群體的方法,包含:體外培養成體幹細胞於一生物相容性高分子形成的一薄膜上,其中該生物相容性高分子係為去乙醯度為60~100%之幾丁聚醣、分子量為9,600~132,000之褐藻酸鹽、分子量為64~96kDa之聚己內酯或其任一組合;以及收集由成體幹細胞聚集成之一球體細胞群體,其中該球體細胞群體會擴大且具有自我更新及分化(differentiation)為一體細胞的能力。 A method for producing adult stem cells as a spheroid cell population, comprising: culturing adult stem cells in vitro on a film formed by a biocompatible polymer, wherein the biocompatible polymer is deacetylated 60 to 100% chitosan, alginate having a molecular weight of 9,600 to 132,000, polycaprolactone having a molecular weight of 64 to 96 kDa, or any combination thereof; and collecting a population of spheroid cells aggregated by adult stem cells, The spheroid cell population expands and has the ability to self-renew and differentiate into cells. 如申請專利範圍第1項所述之方法,其中該成體幹細胞選自由神經幹細胞、神經前驅細胞、脂肪幹細胞、牙齦幹細胞、骨髓間葉幹細胞、肺幹細胞及胎盤幹細胞所組成之群組。 The method of claim 1, wherein the adult stem cells are selected from the group consisting of neural stem cells, neural precursor cells, adipose stem cells, gingival stem cells, bone marrow mesenchymal stem cells, lung stem cells, and placental stem cells. 如申請專利範圍第1項所述之方法,其中該生物相容性高分子薄膜可由塗佈或接枝的方式被覆於任何基材上。 The method of claim 1, wherein the biocompatible polymeric film is coated onto any substrate by coating or grafting. 如申請專利範圍第1項所述之方法,其中該去乙醯度為60~100%之幾丁聚醣進一步與透明質酸結合,且幾丁聚醣與透明質酸的比例約為3:0.177至3:4.425(w/w)。 The method of claim 1, wherein the chitosan having a deacetylation degree of 60 to 100% is further combined with hyaluronic acid, and the ratio of chitosan to hyaluronic acid is about 3: 0.177 to 3: 4.425 (w/w). 如申請專利範圍第1項所述之方法,其中該去乙醯度為60~100%之幾丁聚醣進一步與銀耳多醣結合,且幾丁聚醣與銀耳多醣的比例約為3:0.4至3:4.5(w/w)。 The method according to claim 1, wherein the chitosan having a deacetylation degree of 60 to 100% is further combined with the tremella polysaccharide, and the ratio of the chitosan to the tremella polysaccharide is about 3:0.4 to 3:4.5 (w/w). 如申請專利範圍第1項所述之方法,其中該分子量為64~96kDa之聚己內酯進一步與透明質酸結合。 The method of claim 1, wherein the polycaprolactone having a molecular weight of 64 to 96 kDa is further combined with hyaluronic acid. 如申請專利範圍第1項所述之方法,其中該體細胞為一神經細胞。 The method of claim 1, wherein the somatic cell is a nerve cell. 如申請專利範圍第2項所述之方法,其中該球體細胞群體進一步具有 分化為一心肌細胞或一軟骨細胞的能力。 The method of claim 2, wherein the spheroid cell population further has The ability to differentiate into a cardiomyocyte or a chondrocyte. 如申請專利範圍第8項所述之方法,其中當該球體細胞群體為該脂肪幹細胞時,會分化為該心肌細胞。 The method of claim 8, wherein when the spheroid cell population is the adipose stem cell, the cardiomyocyte is differentiated. 如申請專利範圍第9項所述之方法,進一步包含使該脂肪幹細胞與5-azacytidine接觸,使脂肪幹細胞分化為該心肌細胞。 The method of claim 9, further comprising contacting the adipose stem cells with 5-azacytidine to differentiate the adipose stem cells into the cardiomyocytes. 如申請專利範圍第8項所述之方法,其中當該球體細胞群體為該牙齦幹細胞、該脂肪幹細胞、或該胎盤幹細胞時,會分化為該軟骨細胞。 The method of claim 8, wherein the spheroid cell population is the gingival stem cell, the adipose stem cell, or the placental stem cell, and differentiates into the chondrocyte. 如申請專利範圍第11項所述之方法,進一步包含使該牙齦幹細胞、該脂肪幹細胞、或該胎盤幹細胞與一轉型生長因子β3(TGF-β3)接觸,使分化為該軟骨細胞。 The method of claim 11, further comprising contacting the gingival stem cell, the adipose stem cell, or the placental stem cell with a transforming growth factor β3 (TGF-β3) to differentiate into the chondrocyte. 一種具有分化能力的成體幹細胞,係由以下方法所製成,包含:使一成體幹細胞與一生物相容性高分子形成的一薄膜接觸一段有效時間,其中該生物相容性高分子係為去乙醯度為60~100%之幾丁聚醣、分子量為9,600~132,000之褐藻酸鹽、分子量為64~96kDa之聚己內酯或其任一組合;其中該成體幹細胞會形成一球體細胞群體,該球體細胞群體會擴大並具有分化為一神經元細胞、神經膠細胞、軟骨細胞或心肌細胞的能力。 An adult stem cell having differentiation ability is prepared by contacting an adult stem cell with a film formed of a biocompatible polymer for an effective period of time, wherein the biocompatible polymer system It is a chitosan with a degree of acetylation of 60-100%, alginate with a molecular weight of 9,600-132,000, polycaprolactone having a molecular weight of 64-96 kDa or any combination thereof; wherein the adult stem cells form a A population of spheroid cells that expand and have the ability to differentiate into a neuronal cell, a glial cell, a chondrocyte, or a cardiomyocyte. 如申請專利範圍第13項所述之成體幹細胞,其中該成體幹細胞選自由神經幹細胞、神經前驅細胞、脂肪幹細胞、牙齦幹細胞、骨髓間葉幹細胞、肺幹細胞及胎盤幹細胞所組成之群組。 The adult stem cell according to claim 13, wherein the adult stem cell is selected from the group consisting of a neural stem cell, a neural precursor cell, a fat stem cell, a gingival stem cell, a bone marrow mesenchymal stem cell, a lung stem cell, and a placental stem cell. 如申請專利範圍第13項所述之成體幹細胞,其中該生物相容性高分子進一步包含一具有如SEQ ID NO:1胺基酸序列之纖維素結合功能區域-RGD貼附序列(CBD-RGD)。 The adult stem cell according to claim 13, wherein the biocompatible polymer further comprises a cellulose binding functional region-RGD attachment sequence having the amino acid sequence of SEQ ID NO: 1 (CBD- RGD). 如申請專利範圍第13項所述之成體幹細胞,其中該去乙醯度為60~100%之幾丁聚醣進一步與透明質酸結合,且幾丁聚醣與透明質酸 的比例約為3:0.177至3:4.425(w/w)。 The adult stem cell according to claim 13, wherein the chitosan having a deacetylation degree of 60 to 100% is further combined with hyaluronic acid, and the chitosan and hyaluronic acid are used. The ratio is approximately 3:0.177 to 3:4.425 (w/w). 一種醫藥組合物,包含如申請專利範圍第13項所述之成體幹細胞及一藥學上可接受載體。 A pharmaceutical composition comprising the adult stem cells of claim 13 and a pharmaceutically acceptable carrier. 一種篩選具有自我更新能力成體幹細胞的方法,包含使候選成體幹細胞與一生物相容性高分子形成的一薄膜接觸一段有效時間,然後判定具有形成球體細胞群體的成體幹細胞為具有自我更新能力的成體幹細胞,其中該生物相容性高分子係為去乙醯度為60~100%之幾丁聚醣、分子量為9,600~132,000之褐藻酸鹽、分子量為64~96kDa之聚己內酯或其任一組合。 A method for screening adult stem cells with self-renewal ability, comprising contacting a candidate adult stem cell with a film formed by a biocompatible polymer for an effective period of time, and then determining that the adult stem cells having the spheroid cell population are self-renewing The ability of the adult stem cells, wherein the biocompatible polymer is a chitosan having a deacetylation degree of 60 to 100%, a brown alginate having a molecular weight of 9,600 to 132,000, and a polycondensation having a molecular weight of 64 to 96 kDa. Ester or any combination thereof. 如申請專利範圍第18項所述之方法,其中該有效時間較佳為1日到4日。 The method of claim 18, wherein the effective time is preferably from 1 day to 4 days. 如申請專利範圍第18項所述之方法,其中該生物相容性高分子薄膜可由塗佈或接枝的方式被覆於任何基材上。 The method of claim 18, wherein the biocompatible polymeric film is coated onto any substrate by coating or grafting.
TW099138813A 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells TWI419970B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW099138813A TWI419970B (en) 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells
CN201110355162.3A CN102533640B (en) 2010-11-11 2011-11-10 Method for generating adult stem cells into spheroid cell populations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW099138813A TWI419970B (en) 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells

Publications (2)

Publication Number Publication Date
TW201219572A TW201219572A (en) 2012-05-16
TWI419970B true TWI419970B (en) 2013-12-21

Family

ID=46341677

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099138813A TWI419970B (en) 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells

Country Status (2)

Country Link
CN (1) CN102533640B (en)
TW (1) TWI419970B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI550088B (en) * 2014-01-16 2016-09-21 國立台灣大學 Method for rejuvenating aged cells and composition thereof
CN107250350B (en) * 2014-11-21 2021-05-25 台湾粒线体应用技术股份有限公司 Method and pharmaceutical composition for continuously maintaining growth of motor neuron precursor cells
KR101796765B1 (en) * 2015-10-02 2017-11-13 순천향대학교 산학협력단 Compositions containing SPHEROID CELL AGGREGATES for enhance ovary function and preparation method of the same
KR101795633B1 (en) * 2016-05-23 2017-11-10 가톨릭대학교 산학협력단 Method of Forming Spheroids of Stem cell
CN108220230B (en) * 2018-02-01 2022-01-18 上海莱馥医疗科技有限公司 Method for separating and culturing human adipose-derived stem cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200925278A (en) * 2007-12-07 2009-06-16 Ling-Hui Huang Method for preserving proliferation and differentiation potential of undifferentiated cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119398B2 (en) * 2004-12-30 2012-02-21 Primegen Biotech Llc Adipose-derived stem cells for tissue regeneration and wound healing
CN101215545A (en) * 2007-12-31 2008-07-09 浙江大学 Method for obtaining neural progenitor cells induced by bone marrow mesenchymal stem cells
JP2012520672A (en) * 2009-03-20 2012-09-10 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ Culture of pluripotent and multipotent cells on microcarriers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200925278A (en) * 2007-12-07 2009-06-16 Ling-Hui Huang Method for preserving proliferation and differentiation potential of undifferentiated cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Gan Wang., "The effect of topology of chitosan biomaterials on the differentiation and proliferation of neural stem cells", Acta Biomaterialia 2010, 6(9), 3630-3639 摘要 *
Shan-hui Hsu., "Evaluation of Chitosan-alginate-hyaluronate Complexes Modified by an RGD-containing Protein as Tissueengineering Scaffolds for Cartilage Regeneration", Artificial Organs 2004, 28(8), 693-703 摘要 *

Also Published As

Publication number Publication date
TW201219572A (en) 2012-05-16
CN102533640A (en) 2012-07-04
CN102533640B (en) 2015-07-08

Similar Documents

Publication Publication Date Title
Ansari et al. Alginate/hyaluronic acid hydrogel delivery system characteristics regulate the differentiation of periodontal ligament stem cells toward chondrogenic lineage
EP2983728B1 (en) Polycaprolactone microcarriers for stem cell culture and fabrication thereof
CN105934511B (en) Culture medium composition
US8241902B2 (en) Preparation of adult stem cell-derived connective tissue progenitors
CA2768376C (en) Methods and compositions for in vitro and in vivo chondrogenesis
Ji et al. Bioactive nanofibers induce neural transdifferentiation of human bone marrow mesenchymal stem cells
US10603407B2 (en) Collagen matrix for cell therapy
JP6660080B2 (en) Undifferentiated cell culture method using sustained release composition
Kai et al. Potential of VEGF‐encapsulated electrospun nanofibers for in vitro cardiomyogenic differentiation of human mesenchymal stem cells
Bicer et al. Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells
WO2012142569A2 (en) Decellularized extracellular matrix
US9649341B2 (en) Collagen matrix for tissue engineering
TWI419970B (en) A method to producing a spheroid population of adult stem cells
TW202024320A (en) Medium composition for suspension culture of adhesive cells
Su et al. Effect of chitosan conduit under a dynamic culture on the proliferation and neural differentiation of human exfoliated deciduous teeth stem cells
WO2024114336A1 (en) Preparation method for cartilage microtissue derived from differentiation of human pluripotent stem cells and use
TW202134437A (en) Mirna-based pharmaceutical compositions and uses thereof for the prevention and the treatment of tissue disorders
WO2022259721A1 (en) Method for producing mesenchymal stem cells
CN113383068A (en) Implantable constructs, methods of making and uses thereof
Ninu et al. Isolation, proliferation, characterization and in vivo osteogenic potential of bone-marrow derived mesenchymal stem cells (rBMSC) in rabbit model
US20140178994A1 (en) Methods and Compositions for In Vitro and In Vivo Chondrogenesis
JP2022189188A (en) Method for producing mesenchymal stem cell
US20110076254A1 (en) Porous scaffolds for stem cell renewal
Breyner et al. Cartilage tissue engineering using mesenchymal stem cells and 3D chitosan scaffolds–in vitro and in vivo assays
Widera Effects of 3D Cell Culture on the Cell Fate Decisions of Mesenchymal Stromal/Stem Cells